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Abstract 
The vertebrate immune response consists of humoral and cellular immune 
reactions, which are mediated mainly by immunoglobulins (Ig) and Tcell receptors (TCR) 
respectively. The organization of Ig and TCR genes has been well established. Each of 
the lg and TCR genes consists of multiple germ line gene segments that rearrange during 
lymphocyte development to generate diverse receptor structures expressed on mature B 
and T cells. The transcriptional regulation of Ig genes has been well studied. The 
octamer motif in the lg gene promoter or enhancer, the E-box and the KB site have been 
functionally characterized. The regulation of transcription factors that bind to these 
sites is well understood. The transcriptional regulation of TCR genes is not as well 
studied as that of lg genes. TCR-a., -13, -y and -<> gene enhancers and a TCR a. gene 
silencer have been reported. Some of the transcription factors that bind to these cis-
elements have been cloned. A T cell-specific transcription factor, GATA-3, may play 
an important regulatory role on the expression of TCR genes in T cells. The promoters 
of TCR genes also have been investigated, however, the transcription factors that 
interact with them have not been characterized. The aim of this thesis was to isolate 
and characterize transcription factors that function in TCR gene transcription. 
A eDNA clone htj3, encoding a zinc finger protein that binds to the promoter 
region of the human TCR gene Vj38.1, was cloned from a human peripheral blood T cell 
library. The region of this protein containing four zinc fingers of the class Cys2-X12-
His2 may be responsible for DNA binding to the TCR Vj38.l promoter sequence 
GAAGTTGGGGGTGGTG. A putative transcriptional activation domain that is highly 
negatively charged has also been found in htj3. Analysis of expression of htl3 mRNA 
reveales similar expression levels in Hela cells, Jurkat T cells, Ramos B cells and U -937 
monocyte line. In addition to binding to the human TCR V(38.1 promoter, htl3 also can 
bind to the mouse TCR gene a. silencer. The comparison of htj3 binding sites between 
the human TCR Vj38.1 promoter and the mouse TCR gene a. silencer reveals a core 
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sequence of the CACCC box. Gel-shift assay analysis of five repeats of the CACCC 
box with bacterially expressed htl3 protein indicates that htl3 can bind to the CACCC 
box. Gel-shift assays of the CACCC box with nuclear extracts from various cell lines 
reveal four common bands in T cell, B cell, monocyte and Hela cell lines, and one extra 
band in Hela cell extracts. CAT assay analysis indicates the CACCC box is essential for 
efficient transcription of the Vl38.l promoter. Cotransfection with a htl3 expression 
plasmid and a reporter plasmid show that htl3 can activate human TCR Vl38.l gene 
transcription. Htl3 also is able to counteract the silencing effect of the TCR a. silencer. 
Htl3 may have an interaction with the cAMP response element binding protein (CREB) 
to negatively regulate human Vl38. l gene transcription in Hela cells, and that negative 
effect is not significant in Jurkat T cells. The CACCC box has been found in almost all 
Vf38 subfamily members ( 4 of 5 Vl38 members in human, and 2 of 3 Vf38 members in 
mouse), and both TCR a. and f3 enhancers in human and mouse. These results suggest 
that the CACCC box binding protein may have an important function in the immune 
system. 
A murine zinc finger protein (M-zif) has been isolated and characterized. It has 
four fingers in the zinc finger domain, the putative DNA binding domain. Also, a 
glutamine-rich region was found, which may be involved in transcriptional activation. 
A previously reported eDNA molecule was shown to contain in opposite orientatioins the 
coding regions of both the interleukin-2 receptor a. (IL-2Ra.) and M-zif genes. The 
results presented here indicate that the eDNA is a chimeric molecule resulting from 
cloning artifact. The zinc finger domain of M-zif is highly homologous to that of htl3 , a 
human T cell receptor Vl38. l promoter binding protein. They may have a similar DNA 
binding site. M-zif is not the mouse equivalent of htf3. 
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I. TRANSCRIPTION OVERVIEW 
Transcription in eukaryotes is governed by three different RNA polymerases, 
termed RNA polymerase I, II and III. Each class of RNA polymerase has its special 
functions. RNA polymerase I transcribes ribosomal RNA, RNA polymerase II 
transcribes messenger RNA, and RNA polymerase III transcribes tRNAs and other small 
RNAs (I -3). The transcription of an eukaryotic gene by RNA polymerase is governed 
by cis-acting elements: a promoter, an enhancer and sometimes a silencer (4-5). A 
promoter is a region of DNA sequence that is required for initiation of transcription. It 
includes the start site of transcription, often has a TAT A box and a set of upstream 
elements. An enhancer is a DNA element located in or around a gene that increases the 
level of transcription, independent of its position or orientation. A silencer has the basic 
features of an enhancer, but decreases the level of transcription. 
Transcription factors bind and recognize specific sequences within cis-acting 
elements to regulate gene expression. These proteins have at least two basic domains, 
one that recognizes a specific DNA sequence motif in a given promoter or enhancer and 
a second domain that interacts with other transcription factors or RNA polymerase to 
regulate the level of transcription (6-7). On the basis of protei~ structural motifs at the 
DNA binding domains, transcription factors can be divided into four groups: helix-
turn-helix, zinc finger, leucine zipper and helix-loop-helix (fig. I) (6-7). 
A. DNA binding domains 
1). Helix-turn-helix 
The first characterized structural motif of a DNA-binding domain is the helix-
turn-helix found in prokaryotic activator and repressor proteins (8). The basic structure 
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of this class of proteins is two a.-helices that are separated by a 13-turn. In eukaryotic 
organisms the helix-turn-helix motif first was found in several regulatory proteins 
encoded by homeotic genes of Drosophila embryogenesis (9-1 0). A conservative DNA 
segment of approximately 180 bp in length is characteristic for these homeotic genes, 
termed homeobox. Sequences homologous to the homeobox have been isolated from 
higher organisms, such as mammals (II). The homeobox proteins are characterized by a 
helix-turn-helix motif in which one of the helices called the "recognition helix" directly 
binds to specific DNA sequences. The N-terminal helix is 8 amino acids long, the turn 
is 3 amino acids long, and the C-terminal helix is 9 amino acids long. The homeobox 
proteins are capable of sequence-specific DNA binding in vitro (12). In cultured 
Drosophila cells and in a transient expression system, the homeobox proteins have been 
shown to either stimulate or repress transcription of certain genes (13-14). They are 
transcriptional regulators active during development. Also there is a subclass of 
transcription factors within the homeobox protein family that has a common bipartite 
domain, termed POU domain, which was first described in the mammalian PIT -1, OCT-
1, OCT -2, and C. elegans unc-86 gene products ( 15). The POU domain contains a 
homeodomain and a second region, the POU box. The POU box is unique to this 
subclass. 
2). Zinc finger 
Zinc finger motifs were defined first as a DNA-binding structure in the RNA 
polymerase III transcription factor TFIIIA that is involved in the expression of the 
Xenopus laevis 5S ribosomal RNA gene (16). Several zinc fingers containing proteins 
have been described that function in transcription mediated by RNA polymerase II (17.). 
These zinc fingers containing transcription factors can be classified as two types. The 
first type is TFIIIA-Iike zinc fingers that consist of two cysteine and two histidine 
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residues that form a domain by coordinating a zn2+ ion; there is a region of 
approximately 12 amino acids between zinc fingers. The sequence in this region is quite 
conservative among species. This type of zinc finger motif has been found in a variety 
of eukaryotes, notably the mammalian transcription factor Sp 1 (18-19) and Drosophila 
Kruppel proteins (20). The zinc finger region and zinc are necessary for the DNA 
binding function of these transcription factors. The second class of zinc finger motif 
has two pairs of cysteines. Mutations at the key cysteine residues result in elimination 
of sequence-specific DNA-binding function (21). This class of zinc finger motif has 
been observed in a :variety of DNA-binding proteins, from mammalian hormone 
receptors (22-23) to yeast regulatory proteins (24). The zinc finger containing proteins 
exhibit many DNA sequence specificities. The highly conserved amino acids in the 
finger region are not responsible for the DNA binding specificities, but may provide a 
common structure for the binding domain. The crystal structure of a zinc finger 
protein, mouse immediate early protein Zif268, suggests that some of the nonconserved 
amino acid residues determine the specificity (25). 
3). Leucine zipper 
The third class of DNA binding protein is called leucine zipper, which was first 
described for the rat liver enhancer binding protein c/EBP (26). The sequence similarity 
among c/EBP and several oncogene products (Fos, Myc, and Jun), and also a yeast 
regulatory protein (GCN4) was noted. The common structure of these transcription 
factors is a region of highly conserved sequence with positively charged amino acids 
immediately followed by a region of a strict heptad repeat of leucine residues, named 
"leucine zipper" (26). The leucine zipper is required. for dimerization of proteins in this 
group. The basic region is necessary for DNA binding, and the leucine zipper region is 
believed to assist this basic region to form a DNA binding structure (26). Other 
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proteins, for example, OCT -2 contains a leucine zipper without the conserved basic 
region, and is believed to use its homeodomain for specific DNA binding (27). 
4). Helix-loop-helix 
The fourth class of DNA binding motif termed helix-loop-helix was identified in 
several regulatory proteins, the daughterless and achete scute gene products in Drosophila 
(28-29), the Myc, MyoD, and two immunoglobulin enhancer binding proteins in 
mammals (30-31). They all contain a conserved basic region followed by a motif that 
consists of two amphipathic helices separated by a loop of variable length. The basic 
and helix-loop-helix (HLH) regions allow these proteins to dimerize with themselves 
and/or with other members of the family, and bind to DNA (32-34). The HLH motif is 
mainly for dimerization, while the basic region is responsible for DNA binding and 
functional specificity (34). The HLH proteins lacking a basic region may regulate 
negatively other HLH proteins by forming a nonfunctional heterodimer (35). Besides 
these four classes of structural motifs (helix-turn-helix, zinc finger, leucine zipper and 
HLH), there are other transcription factors, for example heat-shock transcription factors 
(36-37), CTF/NFI (38}, HAP2 and HAP3 (39-40}, and TFIID (41-42), which fall outside 
the four classes. It is anticipitated that more new DNA binding domain motifs will be 
identified. 
B. Transcriptional activation domains 
The transcriptional regulation function of DNA binding proteins is dependent 
upon a region of sequence that is separated from the DNA binding domain. One 
transcription factor can have more than one transcriptional activation domain and can be 
interchangeable. When the transcriptional activation domain from one factor is linked to 
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the DNA binding domain of another factor, the chimeric transcription factor retains the 
DNA binding specificity and transcriptional activation function of the original 
transcription factor. Transcriptional activation domains can be categorized into three 
classes: acidic domains, glutamine-rich domains and proline-rich domains (fig. 2) ( 43). 
1). Acidic domain 
The transcription activation domains were first identified in the yeast regulator 
proteins GAL4 and :GCN4 (44-46). The activation domains of these two factors consist 
of a region of amino acids with two common features. They are highly negatively 
charged and can form an amphipathic a.-helix, although they do not have obvious 
sequence similarity. When the acidic domain is linked to a different DNA binding 
domain, it can activate the transcription of a reporter gene according to the DNA 
binding domain specificity. This has been shown in yeast and in cells of many kinds of 
higher organisms (44). This acidic domain has been found in mammalian transcription 
factors AP-1/Jun and TEF-3 and correlates with their transcriptional activation function 
(47-48). The acidic domain may interact with transcription initiation components, very 
likely the TAT A box binding protein TFIID and works universally on gene transcription 
(42, 49). The evidence is that the herpes simplex virion protein VP16 that has a strong 
acidic domain binds to both human and yeast TFIID selectively (50). 
2). Glutamine-rich domain 
The second class of transcriptional activation domains was found in the human 
Spl factor (51). Spl has two strong activators containing approximately 25% glutamine 
and few charged amino acid residues. This glutamine-rich motif also was found in 
Drosophila antennapedia ultrabithorax (51), in yeast HAPl and HAP2 (52-53), and in 
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mammalian OCT-I, OCT-2, TFUD and Jun (54-56, 47,42). There are no obvious 
sequence homologies among these glutamine-rich regions. The glutamine-rich region 
from one transcription factor can be linked to the DNA binding domain from another 
transcription factor and still have activation function (51). The glutamine-rich activator 
may work only in certain cell types, for example, it has not been shown that the 
glutamine-rich domains from Sp I can activate transcription in yeast. As proposed, the 
glutamine-rich domain may either bind to an acidic activator that is attached to TFIID, 
or contact a part of TFIID different from that recognized by an acidic activator, or 
interact with another component of the transcriptional initiation complex other than 
TFIID (49). By using one of these three mechanisms, glutamine-rich domains can 
activate gene expression. 
3). Proline-rich domain 
The third class of activation domain was defined in CTF/NF-1 (43). The 
proline-rich domain of CTF can activate transcription when it forms a chimeric 
transcription factor with other DNA binding domains. Besides CTF, there are many 
mammalian transcription factors containing a proline-rich domain, for example Jun and 
OCT -2 ( 48,55-56). 
All three classes of transcriptional activation domains are likely to carry out their 
functions by interacting with other proteins. Although acidic domains interact with the 
TA TA box binding protein TFIID (50), whether the glutamine-rich and proline-rich 
domains contact different parts of TFIID is unknown. It is possible that both 
glutamine-rich and proline-rich domains interact with other components in the 
transcription initiation complex and activate transcription. 
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II. OVERVIEW OF IMMUNOGLOBULIN AND T CELL RECEPTOR GENE 
STRUCTURE 
The vertebrate immune response consists of humoral and cellular immune reaction 
against foreign invaders and abnormal self -proteins. The humoral immune response is 
mainly mediated by B lymphocytes and their secreted molecule, an immunoglobulin (Ig) 
that recognizes antigen alone. The cellular immune response largely depends on T 
lymphocytes that bear T cell receptors (TCR) on their surface that recognize antigen 
peptide in association with class I and class II major histocompatibility complex (MHC) 
proteins, termed MHC restriction (57). T cells acquire MHC restriction during their 
maturation in the thymus (58). Mature T cells express either a.l3 or yo TCR molecules on 
their surface. T cells have at least two subclasses, helper T cells that recognize foreign 
antigen in association with class II MHC molecules and cytotoxic T cells that recognize 
foreign antigen and the class I MHC molecule. Besides TCR, there are a number of 
accessory molecules playing important roles in T cell recognition and activation, notably, 
CD3, CD4 and CD8. Usually helper T cells express CD3 and CD4, and cytotoxic T cells 
express CD3 and CD8. The CD3 molecule consists of y, 8, £, l;; and 11 chains (59). 
The structure of lg and TCR genes is known (fig. 3). The lg genes have three 
families, the heavy chain family and the K and A. light chain gene families (60). Every 
variable gene is composed of two parts, a variable gene segment (V) and a constant gene 
segment (C) joined through a DNA rearrangement process. A VL gene is produced by 
combining a V gene segment and a joining (JL) gene segment, while a VH gene is 
constructed from three gene segments, a V, a diversity (D) and a J gene segment. Then 
similar rearrangement process occurs with TCR genes. Va. and Vy genes are generated 
by V and J gene segment joining; Vi} and VB genes are formed by combining V, D, and 
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J gene segment (61-62). The TCR o genes are located within the TCR a locus (63). 
The C0 gene is located 5' of the Ja gene segments, and both Va and Yo may rearrange 
to it. The variable gene segment rearrangement is mediated by rearrangement signals 
located 3' to the V gene segments, 5' to the J gene segments, and on both sides of the D 
gene segments (62). The rearrangement signal consists of a conserved heptamer, 5' 
CACAGTG 3' and an A/T rich nanomer, separated by a spacer sequence of either 12 or 
23 base pairs (64-65). Usually the gene segments with different spacer length can join 
each other (63-64). 
Transfected TCR genes can rearrange in B cell lines (66). Hence, the VDJ 
joining of TCR and Ig genes may use a common recombination machinery. Both RAG-
I and RAG-2 gene products are capable of providing fibroblasts with the competence to 
carry out VDJ joining. These two genes are expressed in immature B and T cells, but 
not in mature cells of either kind (67-68). Both RAG-1 and RAG-2 deficient mice 
have no mature B and T lymphocytes. The arrest of B and T cell differentiation occurs 
at an early stage and results from the inability of initiating V(D)J rearrangement (69-70). 
The exact functions carried out by RAG-I and RAG-2 in gene rearrangement are not 
clear. 
Generating diversity in the antigen receptor is necessary to accommodate the 
large number of antigens in the environment. Both the Ig and TCR genes use similar 
mechanisms for diversification during and after gene rearrangement. The first 
mechanism is germline diversity. Both Ig and TCR genes have a large number of 
different gene segments for forming their variable region genes. The combinatorial 
joining of these gene segments is the second mechanism, and during the joining process, 
nucleotides can be added or deleted to the joining ends of gene segments. In addition, 
there are multiple translational reading frames in the D gene segments (62). After 
rearrangement, Ig genes employ the third mechanism, termed somatic hypermutation, for 
generating diversity. TCR genes rarely or do not use this mechanism. Somatic 
10 
hypermutation,the acquisition of specific single nucleotide change, can happen 
throughout the V gene and its flanking sequences to generate higher affinity 
immunoglobulin molecules, which is the mechanism of affinity maturation in a 
secondary immune response {62). By using these mechanisms the immune system can 
produce enough antigen receptors to recognize all kinds of antigens in the environment 
(62, 71). 
lg gene rearrangement and expression have four separate stages {72). The firs t 
stage is DH-JH rearrangement, followed by the VH gene segment joining to the DH-JH 
gene segment. The. third step is V K and J K joining that is triggered by heavy chain 
rearrangement. Finally if the K gene has rearranged nonproductively, the A. light chain 
genes rearrange. TCR gene rearrangement and expression can be divided into four 
steps. In the fetal thymus, TCR o and y gene segments rearrange first, followed by DJ3-J 
J3 joining. Vj3 gene segments then rearrange to Dj3-Jj3 to form Vj3-Dj3-Jj3. Finally, the 
Va. and Ja. gene segments rearrange to generate Va.-Ja. (73). There are two different 
lineages of T cell development, the TCR a.j3 lineage and TCR yo lineage (74). The TCR 
yo heterodimers appear before a.J3 in fetal thymocytes. T cell precursors first rearrange y 
and o genes, and those that succeed become yo T cells. Those that failed to produce y 
and o chains may then rearrange TCR j3 and a. loci, and differentiate into a.J3 T cells 
(75). 
III. TRANSCRIPTIONAL REGULATION OF IMMUNOGLOBULIN AND T CELL 
RECEPTOR GENES 
The mammalian bone marrow is one of the best studied model systems of cell 
differentiation. A number of cell lineages are generated from bone marrow pluripotent 
stem cells: the megakaryocyte-platelet lineage, the erythroid lineage, the granuolocyte-
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monocyte lineage and the lymphoid lineage. Both T and B cells are differentiated from 
precursor cells of lympholineage. T and B cell development provide an excellent system 
to study tissue-specific gene expression, and to identify tissue-specific transcripton 
factors. 
A. Transcriptional regulation of immunoglobulin gene expression 
lg gene transcription has been used as a model system to understand B cell-
specific gene expression for many years (Table 1). An octamer motif 5' A TTIGCAT 3' 
or its inversion has been found in all lg promoters (76). Synthetic promoters with the 
octamer and a TAT A box are active only in lymphoid cells, suggesting that the octamer 
motif is lymphoid-restricted (77). However, in some cases, the octamer activates 
transcription in non-B cell types (78-79). The phenomenon was not understood until the 
cloning of OCT -1 and OCT -2 transcription factors (54-56). Both OCT -1 and OCT -2 
can bind to the octamer, and are members of the POU-domain family (15). OCT-1 is 
expressed in a variety of cell types, while OCT -2 is limited to B cells (54-56). This 
suggests that OCT -1 works in a general way and OCT -2 mediates lymphocyte-specific 
activity. Additional transcription factors, OCT -3 and PIN-I, have been identified that 
also interact with the octamer (80-82). 
The lg heavy chain (lgH) gene enhancer was the first cellular enhancer to be 
identified. It is located in the intron between the J and C gene segments. This 
enhancer is B cell-specific (83). B cell- specific binding activities have been observed to 
the octamer motif. Both OCT -I and OCT -2 can bind to the octamer motif in the 
enhancer (54-56). The second element that is active only in B cells is the ).J.B motif (84-
86). A set of homologous motifs in the enhancer is termed the E motifs (87). Molecular . 
cloning of cDNAs for the E motif binding proteins has identified a new family of 
transcription factors, the helix-loop-helix proteins (32). The HLH proteins that bind to 
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the E motifs can be divided into two groups, one group specific for J.LE5 of the lgH 
enhancer and KE2 of the lgK enhancer and another group specific for the E3 motif in 
both the lgH and lgK enhancers. The J.LE5/ KE2 binding proteins include E 12, E47, ITF-
1 and ITF-2. E12, E47 and ITF-1 are derived by alternative splicing from the same 
gene located on human chromosome 19, and ITF-2 is encoded by a different ge ne (32, 
88-90). This group of proteins includes the basic motif and HLH structure (bHLH). 
The J.LE3/KE3 binding proteins have TEF-3, T FEB and USF (or NF-J.LE3) and share a 
dimerization domain leucine zipper structure besides the basic motif and HLH structure 
(bHLH-zip) {91-92). The 60 base pair region of the lgH enhancer that binds bHLH and 
bHLH-zip proteins is sufficient for B cell-specific transcription (93). ITF-1 and TEF-3 
can directly activate transcription when they bind to their cognate binding sites within 
the enhancer region of a gene (88,91). TEF-3 has an a-helical and negatively charged 
region that is the transcription activation domain (91 ). In non-B cells, there may be 
negative regulation restricting HLH protein-mediated activation. It has been proposed 
that a repressor in non-B cells binds the J.LE5 site, and causes inactivation of the J.LE3 
site, since overexpression of ITF -1 in fibroblasts can activate transcription through the J.1 
E5 site and relieves repression. In B cells, the J.LE5-binding repressor may be absent or 
ITF-1 has a much higher binding affinity in B cells than in fibroblasts because of 
different post-translational modification of ITF-1 in different cell types (91-94). The Id 
protein that has the HLH structure but does not contain the basic amino acid region can 
bind to bHLH protein to form a heterodimeric complex, leading to inactivation of bHLH 
protein (35). It has been shown that Id inhibits the activity of both lgH and lg~e 
enhancers in B cells (95). 
The lgK enhancer also is located in the intron between the J and C gene 
segments. It has at least two important motifs , KB and E . The transcription factor NF-K 
B recognizes the 10-bp KB motif that is crucial for enhancer function (83). NF-KB 
binding activity is only detected in mature B cells, but can be induced in pre-B cells 
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(96). NF-KB contains two subunits of about 50 and 65 kd (97). The smaller subunit 
contains the DNA binding function (98-99), while the bigger subunit does not bind 
DNA but is essential for inhibition of NF-KB by 1-KB that is a 35 kd inhibitor protein 
(97, 100- 101). Usually cytoplasmic NF-KB is associated with 1-KB in a latent form. 
Upon induction, protein kinases activate NF-KB by phosphorylation and thereby 
dissociate of 1-KB (101). NF-KB translates into the nucleus, binding to its cognate site 
and activating transcription. Many important genes in immune function can be induced 
by NF-KB, including IL-2, IL-2 receptor a. chain, IL-6, TNF-a. and J), MHC class I and 
II genes, and I)-interferon (102). Since NF-KB can be induced in a variety of cells, how 
mature B cells keep NF-KB in an active form constitutively is a very interesting 
question. Another motif in the lgK enhancer is the E box. E protein heterodimers that 
bind to J.LE5 and J.LE3 in the lgH enhancer interact with KE2 and KE3 sites respectively. 
Functional cooperation between E motifs seems very important for enhancer function 
since mutations at a KE site affect enhancer activity dramatically (103). In addition, two 
B cell-specific enhancers that are located downstream of the CH gene and CK gene have 
been found (104-105). The IgH enhancer has an octamer motif and a J.LE5 motif. and 
the lgK enhancer has two potential NF-KB sites and a J.LB motif. Interestingly, the lgK 
enhancer is very strong even in the absence of NF-KB. The detailed regulatory 
functions of these enhancers are not quite clear. 
B. Transcriptional regulation of T cell receptor genes 
1). Transcription in the TCR a. gene 
The promoter of a rearranged TCR a. gene is T cell-specific when t~~ted in a 
CAT assay in which a TCR a. promoter and CAT gene containing plasmid was 
transfected into various cell lines (I 06). A T cell-specific enhancer was found several 
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kilobases downstream from Ca. in both human (107) and mouse (108). These two 
enhancers have 120 base pairs of homology. At least four proteins interact with the 
mouse enhancer. Two of these proteins are not tissue-specific, and the other two 
proteins are T cell-specific (108). In the human TCR a enhancer, four functional 
nuclear protein binding sites, Tal-Ta.4 have been identified. The minimal TCR a 
enhancer is contained within the Tal and Ta.2 sites ( 1 09). The spacing between Tal and 
Ta.2 is critical for enhancer function; 20-25 bp spacing is adequate for enhancer activity 
{110}. Ta.3 and Ta.4 may represent redundant elements, because they compensate for 
mutations in Tal o.r Ta.2 that abolish enhancer activity (109). 
Several transcription factors regulate the activity of the TCR a enhancer (Table 
2). Three cAMP response element binding proteins (CREB) bind to Tal that contains a 
cAMP response element (TGACGTCA) (107, 110-111}. Ta.2 has a pyrimidine-rich 
sequence (CCCTITGAAG) at its 5' end and another pyrimidine-rich sequence 
(CATCCTCT) at its 3' end. Two transcription factors TCF-1 (112) and TCF-la. (113) in 
the human bind to the 5' end pyrimidine-rich sequence (Table 2). LEF-1 seems to be 
the mouse homolog of the human TCF-la. (114). These proteins contain a DNA-binding 
domain that has high homology to the DNA binding domain of proteins in the high 
mobility group (HMG) family. LEF-1 is expressed in T cells of all stages and mouse B 
cells. TCF is expressed only in T cells. The binding protein for the 3' end pyrimidine-
rich region of Tet2 is the Ets proto-oncogene product (115), which is expressed in T and 
B cells (I 16}. Mutation in the core Ets-1 binding site in Ta.2 abolishs the minimal a 
TCR enhancer (115}. Just like other Ets family members, Ets-1 contains a conserved 
basic domain and an adjacent a.-helical region ( 117). Both regions are necessary for 
DNA binding (110). Ta.3 has the consensus binding site (AGATAG) for GATA zinc 
finger proteins (109). The. GATA-3 gene encoding the GATA protein has been cloned 
from human (118), mouse (119}, and chicken (120}. Human GATA-3 is expressed in T 
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cells, kidney and brain. Mouse GATA-3 is expressed in early thymocytes (I 10), 
suggesting GATA-3 is a good candidate for a T cell-determining gene. 
In mouse, a negative regulatory element has been identified near the TCR a 
enhancer, which is called the TCR a silencer ( 121 ). The TCR a silencer can down 
regulate transcription from promoters in yo but not in a.f3 T cells by silencing the a 
enhancer activity. The lineage specificity of the a enhancer is achieved through the 
silencing function. 
2). Transcription in the TCR f3 gene 
Tissue specificity of the Vl3 promoter has been addressed by several studies. The 
Vl3 promoter only functions in T cells, not in other cells (I 22). Sequence analysis of 14 
murine Vl3 promoters show a conserved decamer motif (AGTGAT/CG/ATCA) 10-40 bp 
upstream of the TAT A box. This decamer has the cyclic AMP response element (CRE) 
(123). There is a nuclear protein that can specifically recognize the Vl3 promoter region 
(124). The decamer sequence was present also in a human Vl3 promoter. Nuclear 
extracts from various human cell lines can bind to this V(3 decamer (125). It is unlikely 
that the decamer binding protein is solely responsible for tissue specificity of Vj3 
promoters. In another study, within 175 bp upstream of the transcription initiation site 
of the human V(38.1 gene, there are four protected regions, at nucleotide -46 to -68 (I), 
- 72 to -92 (II), - 113 to-134 (III), and - 136 to -17 5 (IV). Nuclear proteins of a variety 
of cell types produced footprints I, III, and IV. Footprint II was produced only by T 
cell extracts, which may be the binding site ofT cell-specific factors (125). In 
agreement with the above result, the Vl3 promoter was only functional in T cells (122). 
The murine and human T cell receptor gene 13 enha ncer is located 3' of Cj32 
(I 26- 128). Within this enhancer region, a number of enhancer motifs have been noted. 
Some of the transcription factors interacting with those motifs have been characterized 
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(Table 2). Two DNase I hypersensitive sites have been described downstream of Cj32 
(129), one site overlapping with the TCR l3 enhancer and the other was expressed only 
in TCR 13- expressing T cells, and is suggested to have a stage-specific regulatory 
function in T cell development. 
3). T cell-specific transcription in the y and o TCR genes 
Experiments with transgenic mice have shown that there is a silencer element in 
sequence flanking the TCR Cy locus. Deletion of this element results in expression of 
the TCR y gene in cells that otherwise express the TCR a.l3 heterodimer (130). A 1.8 kb 
fragment located 3 kb 3' to the Cy exon III was found to display enhancing activity in T 
cells, but it is inactive in non-T cells (131). AT cell lineage-specific enhancer in the Jo 
3-Co intron also has been described. Enhancer activity has been localized to a 250 bp 
region that contains multiple binding sites for nuclear proteins (Table 2) (132-133). 
Since the TCR o gene is located within the TCR a. locus, and the TCR a. gene has its 
own enhancer, it seems that transcriptional control of the TCR o and a. gene is mediated 
by distinct enhancers. 
IV. THESIS 
Although the transcriptional regulation of immunoglobulin genes is well-studied, 
little is known about T cell receptor gene transcription. The octamer motifs are present 
in both the immunoglobulin gene promoter and enhancer, which are responsible for the 
B cell- specific expression of lg genes. The conservative sequences specifically required 
for TCR gene transcription have not been well- characterized in the TCR gene promoters 
and enhancers. T cell-specific TCR gene expression is interesting since there are many 
17 
TCR variable genes and there may be a T cell-specific transcriptional regulation that is 
common to all of these variable genes. Also, T cells play key roles in the immune 
system. T cells recognize foreign antigen through their surface TCR gene products. 
Understanding T cell receptor gene expression will be helpful to understand T cell 
development, tolerance, autoimmunity and other major problems in the immune system. 
Previous studies have shown that the human TCR V!3 gene promoter is T cell specific, 
and that V!3 gene expression may be regulated by T cell-specific transcription factors. 
In my work, I use the well-characterized TCR V!38.l gene promoter as a model to 
understand TCR ge~e transcriptional regulation by DNA binding proteins. My goal was 
to clone T -cell specific transcription factors and study their functions on TCR gene 
expression. 
Chapter l of this thesis describes the isolation and characterization of a eDNA 
clone encoding a DNA binding protein, ht!3, which recognizes a GT rich motif in the 
promoter region of the human TCR VJ38. l gene. Htj3 contains a Cys2-X12-His2 zinc 
finger domain and an acidic region that is the putative transcriptional activation domain. 
Htj3 expression is not T cell specific. 
Chapter 2 further characterizes htj3 as a CACCC box binding factor. The 
CACCC box is essential for efficient human Vj38.l gene expression. Htj3 activates 
human Vj38.1 gene transcription and antagonizes the effect of the mouse TCR a silencer. 
The CACCC motif is observed in many TCR regulatory sequences and other gene 
regulatory regions, suggesting htj3 may have a more general function on gene expression. 
Htj3 may have an interaction with the cAMP response element binding protein (CREB). 
Chapter 3 describes the cloning of a mouse zinc finger containing protein (M-
zif). The zinc finger regions of the M-zif and the htj3 genes are highly similar, 
suggesting they may have the same DNA binding site. Clearly M-zif is not the mouse 
counterpart of htl3. The relationship between the M-zif gene and the interleukin-2 
receptor o. gene is explored and discussed. 
18 
In conclusion, a gene for a CACCC box binding protein has been cloned. This 
CACCC box binding protein activates the human TCR VJ38. l gene and antagonizes the 
effect of the mouse TCR gene a. silencer. It possibly binds to other TCR regulatory 
sequences, and regulates transcription of many genes other than TCR genes. This work 
provides the basis for understanding the regulating function on gene expression of a 
CACCC box binding protein. A gene encoding a mouse zinc finger protein also has 
been cloned, detailed analysis of its function awaits further experimentation. 
19 
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Figure 1 Four types of DNA binding motifs (adapted from Ref. 7). (a) A helix-turn-
helix protein folds in the major groove of the DNA double helix, where it recognizes 
half of the dyad-symmetric binding site. Dimerization of helix-turn-helix protein is 
necessary for stable interaction with DNA sequence. (b) A zinc finger binds to a zinc 
ion though paired cysteine and histidine residues. The cysteins are located in antiparallel 
13 sheets. The histidine residues are in an a.-helical structure. (c) Two polypeptides of a 
leucine zipper protein dimerize via hydrophobic interactions between leucine residues 
(open ovals) located in a. helices. The dark rectangles represent the basic regions that 
recognize the DNA :sequence. (d) Helix-loop-helix (HLH) protein has two amphipathic 
a. helices that are separated by a loop. A basic region that is adjacent to the HLH 
structure is necessary for DNA binding. 
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Figure 2 Three types of transcription activation domains of transcription factors 
(adapted from Ref. 43). (a) Acidic domain that is rich in negatively charged aspartic 
acids and glutamic acids. (b) Glutamine-rich domain, glutamine (Q) is indicated. (c) 






































































































































































































































































































































































































Figure 3 Organization of the murine immunoglobulin (A) and T cell receptor (B) gene 
families (adapted from Ref. 134). Filled boxes are variable region gene segments, and 
open boxes are constant region genes. Numbers are distances in kilobase. Double 
slashes without numbers indicate unknown distances. The TCR 8 gene family is shown 
as an insert to the TCR o. gene family. 
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Table 1 DNA recognition seque nces for Ig trans cription factors 
Motif Loca tion 
Octamer 
ATTTGCAT Ig promoter 
ATTTGCAT IgH e nha ncer 
ATTGACAT IgK enha ncer 
KB 
GGGGACTTTC IgK e nhancer 
E-box 
CAGGTGTT ( J.LES) IgH enhancer 
CAGGTGGC (KE2) IgK enhancer 
CATGTGGC ( J.1E3) IgH enhancer 
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TCR a enhancer Tal 
TCR p enhancer TP2 
TCR P promoter 
TCR a enhancer Ta2 
TCR p enhancer TPS 
TCR o enhancer oE7 
TCR a enhancer Ta2 
TCR P enhancer TP3 
TCR a enhancer Ta3 
TCR P enhancer TP2 




















Characterization of a eDNA Encoding a Zinc Finger Protein That Binds to the Human T 
Cell Receptor Gene V/38.1 Promoter 
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ABSTRACT 
A eDNA clone ht/3, encoding a zinc finger protein that binds to the promoter region of 
the human T cell receptor (TCR) gene V/38. 1, was cloned from a human peripheral 
blood T cell library. The fragment containing four zinc fingers of the class Cys2-X12-
His2 may be responsible for DNA binding to the TCR V/38.1 promoter sequence 
GAAGTTGGGGGTGGTG. A putative transcriptional activation domain that is highly 
negative charged also was found in ht/3. Analysis of expression of ht/3 mRNA revealed 
similar expression levels in Hela cells, Jurkat T cells, Ramos B cells and the U -937 
monocyte line. Interestingly, ht/3 protein also binds to other T cell receptor gene 




T cells recognize antigens in the context of self major histocompatibility complex 
(MHC) using a clonally expressed T cell receptor (TCR). The genes encoding TCR-a, 
-{3, -'Y and -o chains have been characterized (l-10). The four TCR genes are similar 
to immunoglobulin (lg) genes in that each consists of multiple germ line gene segments 
that rearrange during T cell development to generate a mature T cell population with 
clonally distributed receptors ( 11 ). Although both T and B cells derive from common 
bone marrow precursors, the expression of lg and TCR genes is usually lineage specific, 
for example, T cells rearrange and express TCR but not Ig genes. Also, previous studies 
have suggested that both T and B cells use a common mechanism for the assembly of 
TCR and lg genes (12). 
Every TCR gene has two parts, a variable gene region (V) and a constant gene 
region (C). The variable gene is generated through a DNA rearrangement event. The V 
a and V"f genes are produced by combining a V gene segment and a joining (J) gene 
segment, then the VaJa or V"fJ"f joins the C gene upon mRNA splicing. V/3 and Vo 
genes are constructed from three gene segments, a V, a diversity (D) and a J gene 
segment. The D and J gene segments join first, followed by V and DJ joining. Finally, 
the V/3D/3J/3 or VoDoJo combines with the C gene upon mRNA splicing. The TCR o 
genes are located within the TCR a locus, and TCR {3 and 'Y genes are mapped on 
different chromosomes ( 11,13 ). TCR gene rearrangement and expression can be divided 
into four stages (13). In fetal thymus, TCR o and 'Y gene segments rearrange first. 
Those T cells that succeed in productively rearranging o and 'Y genes become "fO T cells. 
Those that fail to produce 'Y and o chains may then produce a D/3-J/3 joining, followed 
by rearrangement of a V/3 gene segment to D/3-J/3 to form a .variable region gene,V/3-D 
{3-J/3. Finally the V a and Ja gene segments rearrange to produce V a-Ja. Those T cells 
that succeed in rearranging TCR {3 and a loci express an a/3 heterodimer on their 
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surface, becoming a{3 T cells. While the organization of four TCR genes has been well 
established, the regulation of rearrangement and expression of these genes in the 
different T cell subsets is relatively unknown. Recent studies have described 
transcriptional enhancers and silencers in the human and murine TCR genes (14-18), and 
two DNA binding proteins that interact with the human TCR a gene enhancer (19-20). 
Several studies have addressed the question of tissue specificity of V{3 promoters. One 
study reveals that the human TCR V{38.1 promoter is only active in T cells (21), 
implying that there are some T cell specific transcription factors that bind to the 
identified V{38.1 promoter. A conserved decamer motif 10-40 bp upstream of the 
TAT A box has been identified in the murine V{3 promoters (22). This decamer also is 
present in the human V{38.1 promoter (23). Royer and Reinherz have shown that there 
are four regions to which transcription factors bind in the 175 bp fragment of the 
human V{38.1 promoter. One of the regions, a 21 bp GT-rich motif 72 bp upstream of 
the transcription initiation site was only protected by nuclear extracts from T cell lines, 
not other cells in a DNAse footprinting study (24). The result suggests there may be T 
cell specific transcription factors binding to the 21 bp GT -rich motif. 
We now report the isolation and characterization of a eDNA encoding a DNA 
binding protein that recognizes the 21 bp GT rich motif in the promoter region of the 
human TCR V{38.1 gene. This human TCR {3 gene promoter binding protein (ht{3) 
contains four Cys-His zinc fingers. 
MATERIALS AND METHODS 
Library screening 
A Agtl1 eDNA library prepared with mRNA from PHA-stimulated human 
peripheral blood T cells (Clontech) was screened according to the method of Vinson et 
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al. (25). Plaques (2x 1 o6) were screened at a density of 2x 1 o4 per filter after lytic 
infection of E. coli strain Yl090. The probe for screening the Agtll eDNA library was 
generated starting with the two complementary oligonucleotides corresponding to the 
sequence of human TCR V/38.1 promoter element -72 to -92 (24): 
5' AATTTTAAAGAAGTTGGGGGTGGTG 3' 
3' AATTTCTTCAACCCCCACCACTTAA 5 1 
The probes used in the screening were prepared by nick translation of size-selected, 
double-stranded catenated oligonucleotides using [a32p] dATP and [a32p] dCTP (26). 
The EcoRI inserts from positively selected plaques were subcloned into Bluescript-KS II 
(-) for sequence analysis using the dideoxy chain termination method for both strands 
(26). · A Agtll eDNA library made with Jurkat T cell line derived mRNA following the 
procedure of eDNA SYNTHESIS SYSTEM PLUS (Amersham) was constructed for 
isolating full length ht/3 eDNA. 
Southern and Northern analysis 
Total genomic DNA was isolated from the human T cell lymphoma-derived cell 
line Jurkat. DNA (10 JJ.g) was digested by EcoRI, Hindiii, BamHI and Xbal, resolved 
on a 0.8% agarose gel, and transferred to nylon membrane (Zeta-Probe, Bio-Rad). 
Southern hybridization was carried out at 3rC overnight with 2.5xl06 cpm/ml 
denatured probe (5xSSC, 20 mM Sodium Phosphate pH 6. 7, 10% Dextran Sulfate, 1% 
SDS, 0.5% powdered milk, 100 JJ.gfml denatured salmon sperm DNA, and 50% 
formamide). The washes were carried out in O.lxSSC, 0.1% SDS at 6SOC for 15 minutes, 
and repeated twice. 
The sources of the human RNAs were T cell line Jurkat (ATCC CRL 8163), B 
cell line Ramos (ATCC CRL 1596), Monocyte line U-937 (ATCC CRL 1593), and Hela 
-cells (ATCC CCL2). RNA was isolated from these cell lines by the guanidinium method 
(26). and poly (A)+ RNAs were selected by oligo(dT)-cellulose chromatography (27). 
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For Northern blot analysis, lOJLg of poly (A)+ RNA was resolved on a formaldehyde gel 
(26) and transferred to nylon membrane (Zeta- probe GT, Bio-Rad). The hybridization 
and washes were performed following the procedure recommended by the membrane 
manufacturer (Bio-Rad). RNA molecular weight markers were purchased from GIBCO 
BRL. 
Bacterial expression 
The bacteriophage T7 expression system was used for production of the ht{3 
protein (28). A DNA fragment containing a portion of the ht{3 coding sequence, 
including the four zinc fingers, was created with Ndei and Bell sites at the ends using 
appropriate oligonucleotides and PCR amplification. This was cloned into the Ndel and 
BamH I sites of the vector pET3a. This plasmid was transformed into the strain BL21 
(DE3) that has the T7 RNA polymerase gene under lacuv5 promoter control. 
Transformed bacteria were induced with I mM IPTG at OD600=0.7 for 4 hrs and 
harvested. Extracts were prepared according to the method of Hoey and Levine (29), 
modified by Treisman and Desplan (30). 
DNase I jootprinting 
The probes for DNase I footprinting were either Rsai-Xbai or Hinfi-Ncoi 
fragments from the human V{38. l promoter region. They were isolated from cosmid 
H7. l (23) and labeled at one end using the filling-in method with Klenow DNA 
polymerase (26). DNase I footprinting assays were performed as described by Galas and 
Schmitz (31). The binding reactions were done with 3-5 ng of 32P-labeled DNA and 2 
JLg of poly(I-C) in 30 1!1 for 20 minutes on ice. The composition of the binding reaction 
was according to Fan and Maniatis (32). After binding, 4 1!1 of 100 mM MgCI2 and 
l50mM CaCl2 were added to the reaction, followed by I JLl of freshly diluted DNase I 
(Worthington) at a final concentration of 25 l!gfm!. DNase I digestion was stopped after 
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minute on ice by addition of stop solution described by Hoey and Levine (29). The 
samples were extracted twice with phenol-chloroform (I: I), chloroform once, ethanol 
precipitated and electrophoresed in a 6% polyacrylamide/8M urea gel. 
RESULTS 
Isolation of the htP gene 
The DNA probe containing the sequence -72 to -92 of the human V{38.l 
promoter was used to screen a Agtll expression library constructed from T cell derived 
mRNA. The screening of 2.6xl06 plaques yielded two clones. One of the clones, ht{316 
contained a 1.8 kb insert which was subcloned into BS-KS II (-) for sequence analysis. 
Using the 1.8 kb ht{3I6 insert to rescreen the same library, we found a clone ht{38 
which overlaps with the 3' sequence of ht{316. Another clone ht{33, which has a 1.8 kb 
insert, overlaps for I kb with the 5' sequence of ht{316 (fig. I). It was isolated from a A 
gtll library made with Jurkat T cell line derived mRNA. Southern blotting of Jurkat 
cell line genomic DNA digested by EcoRI, BamHI, Hindiii and Xbal and probed with 
the ht{316 1.8 kb fragment indicates a dominant single band, although some faint bands 
appear upon longer exposure (fig. 2). 
DNA sequence of the htP gene 
The DNA sequence of ht{3 was determined (fig. 3). The sequence predicts a long 
open reading frame of 1362 nucleotides that is terminated by six in-frame stop codons. 
The 3' untranslated region is 666 nucleotides long . The poly A site was not identified. 
The nucleotide sequence of the open reading frame was translated into its corresponding 
454 amino acid sequence. The molecular weight of the ht{3 protein encoded by the full 
length mRNA is approximately 49 kd. Inspection of the amino acid sequence shown in 
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figure 3 indicates that the ht/3 protein has four tandem zinc fingers near the middle of 
the open reading frame. The first two finger motifs have the general form of Cys-X2-
Cys-X3-Phe-Xs-Leu-X2-His-X3-His, originally described in the RNA polymerase III 
transcription factor TFIIIA (33), and also found in several DNA-binding protein 
domains (34). The third and fourth fingers have the modified form of Cys-X2-Cys-
X8-His-X3-His and Cys-X2-Cys-X3-Phe-X6-Leu-X1-His-X4-His respectively (fig.4). 
At the amino terminal side of the zinc finger region there is a highly acidic segment 
(residues 54-99) that has potential of forming an a-helix. This region has a net negative 
charge of -12. Other features of interest in the ht/3 sequence include a highly basic 
segment (residues 129-153) at the amino terminal side of the zinc finger region and 
another basic segment (residues 314-344) downstream of the fingers. 
HtP encodes a protein that can bind to the human TCR V/38.1 promoter 
A fragment of ht/3 (residues 81-445) containing most of the coding region was 
expressed in E. coli. A portion of the acidic region is missing from the expressed 
protein but all four zinc fingers are present. The plasmid pET3a-ht/3 encodes a 40 kd 
protein composed of 365 amino acids. The deduced molecular weight of this protein is 
the same as the observed size from SDS-polyacrylamide gel analysis (fig. 5). 
Crude lysates of E. coli strain BL2l (DE3) containing pET3a-ht/3 were tested for 
DNA binding activity by DNAse I footprinting with the human TCR V/38.1 promoter 
element (fig. 6). The extracts prepared from BL21 (DE3) (pET3a-ht/3), but not BL2l 
(DE3) (pET3a) were found to protect the 16 nucleotides GAAGTTGGGGGTGGTG of 
the V/38.1 promoter from digestion by DNase I. The DNase I footprinting assay was 
done with both coding and noncoding strands of the V/38.1 promoter, and the protected 
regions were about the same. The sequence of the ht/3 binding site detected by the 
footprinting assay is identical to that of the probe used for screening the Agtll 
expression library. Also, it appears that the 365 amino acid residues of the truncated ht 
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{3 protein that includes the four zinc fingers are sufficient for the sequence-specific 
binding of ht{3 protein to DNA. 
Expression of htP mRNA 
To study the expression pattern of the ht{3 gene, RNA was isolated from various 
tissue culture cell lines. Poly (A)+ RNAs were selected by oligo (dT)- cellulose 
chromatography and detected by Northern blot analysis using the 1.8 kb segment of ht{3 
16 as a probe. As shown in figure 7, three RNA species were detected, with estimated 
sizes of 4.2, 7.6 and 8.6 kb. The same blot was rehybridized with the EcoRI-EcoRV 
fragment of ht{33 that does not contain the zinc finger region, and again three RNA 
species of the same size as in figure 7 were seen. To control for potential variation on 
the level of RNA electrophoresed, the blot was rehybridized with a human {3- actin 
probe. Comparable levels of hybridized RNA were observed with the actin probe 
indicating the expression level of ht{3 is not significantly different in these four cell 
lines. 
DISCUSSION 
An oligonucleotide probe to the sequence of the human TCR V{38.1 promoter 
element -72 to -92 was used to isolate a eDNA clone from a Agtll expression library 
prepared from human peripheral T cell mRNA. This eDNA hybridizes to three mRNA 
species present in a variety of cell types, including Hela cells, U - 937 monocyte line, 
Ramos B cell line and Jurkat T cell line. The three mRNA species may reflect 
alternative mRNA splicing of the ht{3 gene or the 7.6 and 8.6 kb mRNA species could 
be unspliced forms of the 4.2 kb RNA. Other eDNA segments containing overlapping 
sequences were isolated from the above library or a library prepared from Jurkat cell 
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line RNA. The sequence of a composite eDNA of 3.6 kb was partially determined. 
Translation of this sequence reveals a long open reading frame of 454 amino acid 
residues encoding a protein of approximately 49 kd. Ht/3 may be a single copy gene 
since Southern blot analysis using digests of human genomic DNA revealed only one 
band. Longer film exposure reveals more bands for each digestion. The ht/3 probe may 
cross hybridize to other genes encoding zinc finger proteins in the genome. 
The DNA binding domain of the ht/3 protein has been localized to a 118 amino 
acid protein fragment that contains four zinc fingers of Cys2-X 12-His2. This conserved 
motif. found in many DNA binding proteins, was first described in transcription factor 
TFIIIA (33). The consensus sequence of the four fingers is Cys-X2-Cys-X3-Phe-X5-
Leu-X2-His-X3-His. Although crystal structure analysis of a zinc finger-DNA complex 
suggests that one finger contacts 3 bp (36), the ht/3 protein recognizes a sequence 
GAAGTIGGGGGTGGTG of approximately 4 bp per finger domain, which also is 
different from analysis of TFIIIA binding to the 5S gene where each domain recognizes 
a 5.5 bp region (33). Examination of the sequences on the ht/3 fingers and their 
binding sites suggests arginine-guanine contacts also may be important for forming the 
finger and DNA complex, as noted in the crystal structure of the mouse immediate early 
protein Zif268 (36). The sequence analysis of the ht/3 protein suggests the negatively 
charged segment that can form an a-helical structure may be involved in transcriptional 
activation as described in the yeast factors GCN4 and GAL4 (37-39), AP-1/Jun 
transcription factors ( 40-4 I) and immunoglobulin heavy chain enhancer binding protein 
(42). The two basic segments may be involved in nuclear localization of ht/3 as proposed 
by Dingwall and Laskey ( 43 ). 
The specific binding of ht/3 protein to the human V/38.1 promoter was shown 
with a DNase I ·footprinting assay (fig. 5). Since the portion of ht/3 protein that includes 
the zinc finger region is able to bind DNA specifically, the finger region is most likely 
responsible for DNA binding. The binding site is approximately 16 nucleotides, 
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GAAGTTGGGGGTGGTG, which is a little different from the site of 21 nucleotides, 
TT AAAGAAGTIGGGGGTGGTG that was detected with T cell line nuclear extracts 
(24). This may be explained by other factors besides ht/3 protein in the T cell nuclear 
extracts that bind to the sequence around ht/3 protein binding sites. Although we do not 
have data on whether ht/3 protein binds as a dimer to DNA, the lack of symmetrical 
structure at the binding site makes this unlikely. 
The data presently available on the ht/3 gene suggest that it may encode a protein 
with transcriptional regulation function, but how it regulates TCR gene expression 
remains to be determined. In addition to the human TCR V/38.1 promoter, the ht/3 
binding site is also present in the human V/38.2 gene promoter. Whether ht/3 protein can 
bind to other human V/3 promoters needs to be tested. Interestingly, ht/3 protein can 
bind to the mouse TCR a silencer characterized by Winoto et al. (16) (data not shown). 
This observation indicates that ht/3 protein may have multiple functions in regulating 
TCR gene expression. Royer et al. previously reported a nuclear extract activity only 
from T cell lines and not other cell lines that could bind the same region as the ht/3 
protein binding site also determined by DNase I footprinting analysis (24). We detected 
ht/3 mRNA in T cells, B cells and other cell lines. 
The question of whether the ht/3 protein plays a role as a T cell specific or 
general transcription factor is unresolved. Although ht/3 mRNA is expressed in various 
cell lines, there may be different ht/3 protein products in different cell lines due to post-
translational modifications. Ht/3 gene products may have functions in T cells that are 
different from those in other cells. It also is possible that ht/3 protein functions as a 
general transcription factor. Since the ht/3 protein binding site is rich in GT, it may 
bind to other GT-rich sequences (GT boxes), just as Spl binds to GC boxes (43). If this 
is the case, ht/3 protein may have more functions in regulating transcription. Finally, 
the isolation of the ht/3 gene provides us with another system to study zinc finger and 
DNA interactions. As more genes encoding zinc finger proteins are cloned, how each 
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finger specifically contacts certain nucleotides can be determined . 
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Acidic Basic Zinc finger Basic 
htl3 protein N -lL----lo:o:b=:'tLJ:II-.x.l?'@l@~'LLL.L-1·-----'1- C 454 amino acids 
I II I I I I 
amino acid No. 
<.n<O_.._... 1\)U)(..) 
.::..w~(j alwt 
p PR5 ht(3 3 f--'--=-------'-~-------~ 1.8 Kb 
*K p P 
ht(3 16 f--------..::._..._..._____L_----l 1.8 Kb 
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ht(3 8 1.6 Kb 
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Figure 1 cDNAs and predicted protein structure of ht(3. The overlapping cDNAs htf316 
and htl38 were isolated from a human peripheral T cell eDNA library, and eDNA htf33 
was isolated from a Jurkat cell line eDNA library. Restriction enzyme sites: K, Kpnl; 
RI, EcoRI; R5, EcoRV; P, PstL A schematic diagram of the predicted htl3 protein 
structure is shown, with three eDNA clones aligned to the protein structure. The 
interesting motifs in the protein are indicated. ".J.." indicates the translation start site and 
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Figure 2 Southern blot analysis of Jurkat genomic DNA probed with the htP 16 clone. 
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1 501 TCGTCII.GTTGGGGGCTCGCA~~rAGJV\GI\TCCGTCAGG/I.GJ\A/I.T/I.C/I.CCC/I.CCTAAGTTA 
S S V G G S I! { ; E 0 1\ S G E I H P P K L 
1561 GTTCTCII.AAAAAATTAII.TAGTAAGI\GAAGTCTGAAACJ\GCCJ\CTGG/\.GCJ\A/I./I.TC/I.Cl\CA 
V L K K:I N S K R S L K Q P L E Q N H T 
1621 ATTTCJ\CCTTT/I.TCCACATATG/\.II.GAGCGAAAGTTTCAAII.GTATGCTTTTG/\.II.CTTGTGG 
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18 0 1 GII.AGI\.AGI\.AGCGGTATCTTCAII.AGCII.AGTI\.ACI\.ACAGCAGGGI\.ATATGCGCTGII.A TGTGG 




































Figure 3 DNA sequence and predicted amino acid sequence of htP. The amino acid 
sequences predicted from the longest reading frame of htP are shown. The zinc finger 
motifs are shown with an underline; the highly acidic segment that occurs amino 
terminal to the zinc fingers is denoted by a double underline, and the charged amino 
acids are circled. Both basic segments that are located before and after the zinc fingers 
are shown with broken underline. The six in-frame stop codons begins at the "*"· 
conse nsus 
htj} 173-193 
htj} 194-22 1 
htj} 222 - 249 
htj} 250-2 78 
T G E K P F Q 
T G E K P F R 
S G E K P Y G 
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E H C N A A F R T N Y H L Q R H V F I 
S Q C D M R F I Q K Y L L Q R H E K I 
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Figure 4 Amino acid sequence of four zinc finger motifs of htf3 protein aligned to a 
zinc finger motif consensus. The top line shows the zinc finger structural motif 
consensus sequence together with the interfinger linker consensus sequence (34). The 
four htf3 zinc finger motifs are shown below the consensus. The amino acids that are 
highly conserved are boxed. "X" with subcript indicates the number of amino acid 
residues between the conserved ones. 
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Figure 5 Accumulation of htl3 protein. Electrophoresis patterns of protein (visualized 
by coomassie brilliant blue staining) are shown for samples collected immediately (0), 
and 0.5, l, 2 and 4 hr after IPTG induction of expression of target DNA. Samples of 
culture ( l 00 J.Ll) were used for electrophoresis through a 12% polyacrylamide gel in the 
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Figure 6 DNase I footprinting assay of coding (a) and noncoding (b) strands of human 
TCR Vj38.1 promoter. G and G/ A, Maxam and Gilbert sequencing ladder. (a) +55 to -
121 bp region of the Vj38.1 promoter, showing a binding site at -72 to -87 bp. (b) -384 
to +25 bp region of the Vj38. 1 promoter, showing a binding site at -72 to -90 bp. In 
both (a) and (b), lane 0, no protein extract. The other lanes contained extract from 
bacteria containing the pET3a-htP expression plasmids (lanes 1-3) or the control pET3a 
















Fig ure 7 Northern blot analysis of poly (A)+ RNAs from various cell lines. Poly (A)+ 
RNAs (10 J..l8) were loaded on each lane. The blot was hybridized with labeled 1.8 kb 
insert of htP 16. 
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Chapter 2 
Transcriptional Regulation of T Cell Receptor Genes Mediated by a Novel CACCC Box 
Binding Protein Htl3 
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ABSTRACT 
Htl3 is a zinc finger containing protein that binds to the human T cell receptor 
(TCR) Vj38.1 gene promoter. Htl3 also can bind to the mouse T cell receptor gene a 
silencer. The comparison of htl3 binding sites between the human TCR Vl38. l promoter 
and the mouse TCR gene a silencer reveals a core sequence of the CACCC box. Gel-
shift assay of five repeats of the CACCC box with bacterially expressed htl3 protein 
indicates that htl3 can bind to the CACCC box. Gel-shift assay analysis of the CACCC 
box with nuclear extracts from various cell lines reveals four common bands in T cell, B 
cell, monocyte and .Hela cell lines; one extra band is seen in Hela cell extracts. CAT 
assay analysis indicated the CACCC box is essential for efficient transcription of the Vl3 
8.1 promoter. Cotransfection with a htl3 expression plasmid and a reporter vector show 
that htj3 can activate the human TCR Vj38.1 gene transcription. Ht13 also is able to 
counteract the silencing effect of the murine TCR a silencer. Htj3 may have an 
interaction with the cAMP response element binding protein (CREB) to negatively 
regulate human TCR Vj38.1 gene transcription in Hela cells, and that negative effect was 
not significant in Jurkat T cells. The CACCC box has been found in almost all Vj38.1 
gene subfamily members, and in both TCR a and 13 enhancers in human and mouse. 
These results suggest that the CACCC box binding protein may have an important 
regulatory function on the immune system. 
67 
INTRODUCTION 
Transcriptional regulation of gene expression in mammals is mediated in part by 
sequence-specific factors that bind to cis-elements such as promoters, e nhancers and 
silencers ( 1, 2). Many of these factors have been characterized and categorized into four 
major gene families according to their DNA binding domain structures: the 
homeodomain, zinc finger, leucine zipper and helix-loop-helix. Some of the factors 
have been shown to be directly involved in regulation of mRNA synthesis. Promoters 
and enhancers usually have sequence binding sites for various transcription factors. 
These factors may act together to regulate specific transcription for each gene in 
mammalian cells. So it is very important to know how these factors interact with DNA 
sequence and how these DNA binding proteins interact with each other. Although a lot 
of transcription factors have been characterized and well studied, the transcription factor 
which binds to the CACCC box has not been isolated. The CACCC box was first 
described in the 13-globin gene promoter region and was required for efficient and 
accurate 13-globin gene expression. Mutation at the CACCC box region strongly reduced 
transcription, suggesting that the CACCC box is an important promoter element (3 ). 
The CACCC box was not only observed in most of the globin gene family, but also in 
the erythroid transcription factor GATA-1 promoter (4), slow/cardiac troponin C gene 
enhancer (5), rat gastric H+ jK+ -ATPase J3 gene promoter (6), glucocorticoid receptor 
gene promoter (7), and mouse immunoglobulin germ-line Cyl gene promoter (8). Very 
likely the CACCC box binding protein functions as a general and important transcription 
factor for gene expression. In addition to activating transcription through inte racting 
with DNA sequences, the CACCC box binding proteins interact with other transcription 
factors to carry out more functions . A human T cell receptor VJ38.I gene promoter 
binding protein, htl3, was characterized in Chapter 1. In this chapter, we report the 
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further characterization of htf3 as a possibly a long-sought CACCC binding protein and 
present functional analysis of htP protein on T cell receptor gene expression. 
MATERIAL AND METHODS 
Oligonucleotides 
The primers for amplifying the murine TCR gene a. silencer I (9) from mouse 
genomic clone T A4:1 (I 0) are: 
Primer 1 5' CTCGAGCAACATGTGGGAAGA 3 1 
Primer 2 5' CAGCTGTCTGTGTGATTCTTG 3 1 
The double-stranded probe used in gel-shift analysis was produced by the following two 
oligonucleotides: 
5' GATCTGGGGGTGGGGTGGGGGTGGGGTGGGGGTGGGG 3 1 
3 1 ACCCCCACCCCACCCCCACCCCACCCCCACCCCCTAG 5' 
The CACCC boxes are indicated. 
The oligonucleotides for gel-shift competition assays have two 17 mer GAL4 factor 
binding sites (1 I). The sequence is: 
5 1 CGGAGTACTGTCCTCCGCGGAGTACTGTCCTCCGCTGC 3' 
3 1 GCCTCATGACAGGAGGCGCCTCATGACAGGAGGCGACG 5 1 
Plasmid construction 
Expression plasmids. The htP full length eDNA (Chapter I) was subcloned into 
the EcoRI site of pSG5, a eukaryotic expression vector (Stratagene) in which the htl3 full 
length eDNA is under the control of the SV40 early promoter. 
Reporter plasmids. The human VP8.l promoter region ( 12) of various lengths 
was subcloned into the pCAT enhancer plasmid (Promega) that has a CAT gene and a 
SV 40 enhancer, but lacks the promoter element. For p Vf38.l CAT, the Msel-BstNI ( -91 
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to +17) fragment of human Vj38.1 was filled-in at the ends using Klenow DNA 
polymerase and then ligated to Xbal digested and filled-in pCAT enhancer plasmid. pL1 
Vj38.1CAT was constructed by filling-in a Haelll fragment (-71 to +14) and subcloning 
it into the pCAT enhancer plasmid as pVj38.1CAT. The oligonucleotide containing five 
repeats of the CACCC was ligated to Hindiii digested and filled in pL1Vj38.1CAT, 
placing the five repeats of the CACCC upstream of the Vj38 . 1 promoter Haeiii fragment. 
This new plasmid is named p0L1Vj38.1CAT. 
The mouse TCR a gene silencer I fragment (9) was made by PCR amplification 
of mouse genomic c;lone T A 4.1 (I 0) and confirmed by ON A sequence analysis. The 309 
bp mouse TCR silencer I fragment was ligated to either Bglll or Xbal cleaved and 
filled-in pCAT Control plasmid (Promega) that has the SV40 promoter, enhancer and a 
CAT gene. The mouse TCR a silencer was placed either upstream of the SV 40 early 
promoter in the case of pControl digested with Bglll (named pControl sil I 5') or 
downstream of the SV40 enhancer when digested with Xbal (named pControl sil 1). 
All the plasmids constructs were confirmed by DNA sequence analysis. 
Bacterial expression of htP gene, gel-shift assay and DNase I footprinting assay 
Bacterial expression of htj3 gene, gel-shift assay and DNase I footprinting assay 
were performed as described in Chapter!. 
Nuclear extract preparation and gel-shift assay 
Hela cells were grown in DMEM media containing 10% FCS (fetal bovine 
serum). U - 937, Ramos and Jurkat cells were grown in RPMI 1640 media containing 
10% FCS. Cells were harvested in log phase and nuclear extracts were prepared 
according to Schreiber et al (13). Gel-shift assays were done using the conditions 
described by Fan and Maniatis (14). Nuclear extracts {10 ~g) were incubated with 2.5 
ng of 32P-labeled probe and 2.5 ~g of poly (1-C) (Boehringer Mannheim) on ice for 20 
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minutes. The reaction mixtures were loaded in a 6% polyacrylamide/0.5xTBE (Tris-
borate- EDT A buffer) gel. 
Transfection and cAMP induction 
Hela cells were transfected with plasmid DNA using liposomes ( 15). Briefly, 
exponentially growing cells were plated in 6-well tissue culture dishes at 5xto5 cells/well 
and grown overnight. Plasmid DNA was mixed with 20 J..lg of Lipofectin reagent 
(GIBCO BRL) in 1 ml serum- free DMEM. I ml DNA/liposome complex was added 
directly to the cells, Incubation for 3 hrs at 37°C was followed with the addition of I 
ml DMEM containing 20% FCS. Cells were harvested 48 hrs after transfection for CAT 
assay analysis. 
The DEAE-dextran method (I6) was used for transfection of the Jurkat cells. 
Cells (5xio6) were incubated in I ml of TBS (Tris-buffered saline) containing plasmid 
DNA and 500 J..lg/ml DEAE-dextran (Promega) for 30 minutes at room temperature. 
The cells were then washed with TBS and incubated in 20 ml RPMI 1640 media 
containing 10% FCS for 48 hrs. As a control for differences in transfection efficiencies, 
0 .5-1 J..lg of a 13"-galactosidase gene containing plasmid (CMV P-gal, a kind gift from 
Ebrahim Zandi, Department of Chemistry and Chemical Engineering, Caltech) was 
included in each transfection. For cAMP induction, forskolin (Sigma, final 10 J..tM) and 
3-butyl- 1-methyl-xanthine (IMX) (Sigma, final 100 J..tM) were added to the culture 
media right a fter transfection (I 7). 
Chloramphenicol Acetyl-transferase (CAT) Assay and j3-Galactosidase Assay 
Cells were harvested by scraping with a rubber policeman (Hela cells), 
centrifuged, and then washed once in PBS (phosphate buffered saline solution). The 
cells are resuspended in 100 J..ll 0.25 M Tris- HCl, pH7.4, and subjected to three cycles of 
freeze-thaw lysis in liquid nitrogen. The subsequent assays were done according to 
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Gorman et at. (18) using 0.2 ~Ci 14c-chloramphenicol (Amersham) and 25 ~g acetyl-
coenzyme A (Sigma) for each reaction. The acetylated and nonacetylated forms of 
chloramphenicol were excised from the thin-layer chromatography, and the amount of 
radioactivity was determined by liquid scintillation counting. 13-galactosidase assays were 
done as described ( 19) using 0-nitro-phenyl-13-D- galactopyranoside (Sigma) as a 
substrate. The amount of ce ll extracts used for CAT assays were optimized according to 
13-galactosidase assay results. 
RESULTS 
HtP binds to the CACCC motif 
In Chapter l, the binding site for htl3 protein in the human TCR Vl38. l promoter 
has been characterized. On the basis of DNase I footprinting with E. coli expressed ht[3 
protein, the sequence of the site is 5' GAAGTTGGGGGTGGTG 3' (fig. 1 ). Other T 
cell receptor gene regulatory regions have been searched for the presence of a ht[3 
binding site. The mouse TCR gene o:. silencer I has a region of sequence (9) that is 
highly similar to the htl3 binding site in the Vj38.1 gene promoter. Crude lysates of E. 
coli strain BL2l (DE3) containing pET3a-htj3 were tested for DNA binding activity by 
DNase I footprinting with the mouse TCR o:. silencer I fragment. The extracts prepared 
from BL21 (DE3) (pET3a-ht[3) can protect the 163-193 bp region of the mouse TCR o:. 
silencer from digestion by DNase I (fig. 2). 
When the htj3 binding sites in both human Vl38.l and mouse TCR gene o:. silencer 
I were compared (fig. 3), a consensus sequence TGGGGGTGG was found, which has 
the complement of the well-known CACCC box (3) in the center. To. find out whether 
only this CACCC motif is necessary for ht[3 protein binding, double-stranded 
oligonucleotides containing five repeats of the CACCC box were synthesized, annealed, 
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and labeled with 32p as probes for gel-shift analysis. The probe can form a DNA-
protein complex with extracts prepared from BL21 (DE3) (pET3a-ht~), but not BL21 
(DE3) (pET3a) (fig. 4). This result clearly shows that CACCC is the core sequence for 
ht~ binding. Very likely htl3 is one of the long-sought CACCC box binding proteins. 
In addition, nuclear extracts from Hela cells, U-937 monocytes, Ramos B cells 
and Jurkat T cells were tested with the same probe containing five CACCC boxes in a 
gel-shift assay (fig. 5). Four common bands (band 1-4) are visible with all nuclear 
extracts tested. However, an additional fast-moving band (band 5) is only seen with 
extracts from Hela cells. To demonstrate the specificity of binding to the CACCC box, 
an excessive amount of unlabeled CACCC containing oligonucleotide or GAL4 binding 
site containing oligonucleotides which have no homology to the CACCC box were added 
to the reaction mixture of 32P-labeled CACCC containing oligonucleotides and either 
Helacell or Jurkat cell nuclear extracts (fig. 6). All bands in the Hela cell extract assay 
are efficiently competed at 20-50 ng of cold CACCC containing fragment, but not with 
50 ng of GAL4 binding site containing oligonucleotide. In Jurkat T cells, Band 1, 2 and 
4 are competed with specific CACCC box containing fragment, while band 3 is not 
competed at 50 ng unlabeled CACCC containing fragment, which is a 20-fold molar 
excess of competitor. 
CACCC motif is important for human TCR V/38.1 gene expression 
To study the importance of the CACCC box in TCR Vl38.l transcription, various 
Vl38. l promoter constructs were made and analyzed for expression in both Hela and 
Jurkat T cells (fig. 7). pVf38.1CAT, which contains the natural CACCC box in the Vl3 
8. 1 gene promoter, has significant CAT activity. But in the case of p~Vl38.l, which has 
a deletion of the upstream CACCC, the CAT activity is dramatically decreased to about 
5% and 2% of the tra nscriptional activity of p Vl38.l CAT in Hela and Jurkat cells 
respectively. The addition of five repeats of the CACCC box upstream of the Vl38.l 
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promoter of p£\8.1 CAT plasmid increased CAT activities greatly, 59% and I 00% of the 
transcriptional activity of p VJ38.l CAT was restored in He Ia and Jurkat cells respectively. 
Ht/3 activates human TCR V/38.1 gene expression and antagonizes the function of the 
mouse TCR a silencer 
To study the regulatory function of htP protein, the full length eDNA of htJ3 was 
subcloned into an eukaryotic gene expression vector under the control of the SV40 early 
promoter (pSG5). The expression plasmids were cotransfected into Hela cells with the 
pVJ38.1CAT plasmi~ that has a VJ38.I promoter containing the CACCC box followed by 
a CAT gene. Due to the presence of endogenous htJ3 protein, cotransfection with the ht 
J3 expression plasmid and reporter plasmid p VJ38.l CAT did not result in significantly 
increased CAT activity, compared to transfection with reporter plasmid alone. However, 
the 2-fold increase in CAT activity is observed consistently (fig. 8). HtJ3 protein is able 
to activate transcription of human VJ38.l gene. 
Besides binding to the VJ38.l promoter, htJ3 also can bind to another TCR 
regulatory sequence, the mouse TCR a. gene silencer I. The regulation of the mouse 
TCR a. silencer I by htJ3 protein was investigated. The presence of the mouse a. silencer 
I downstream of the SV 40 enhancer (pControl sil) or upstream of the SV 40 promoter 
(pControl sil 5') results in decreased transcription by approximately 40% and 67% 
respectively (Fig. 9), while cotransfection of pControl sil or pControl sil 5' with pSG5-ht 
J3 restored the transcription activity to 97% or 61%. This indicates that htJ3 can reverse 
the silencing function of the mouse a. silencer. 
Effects of cAMP on V/38 .1 gene expression 
There is a cAMP response element (CRE) site in the hum~n TCR_ VJ38.l gene 
(fig. 1). This DNA sequence has been shown to mediate cAMP responsiveness of rat 
somatostatin (20). Studies were carried out to investigate the effect of cAMP on VJ38.I 
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gene expression. Both Hela cells and Jurkat T cells were treated with forskolin and 3-
butyl-l-methyl-xanthine (IMX) for cAMP induction right after transfection. The 
transcription activity of VP8.l was decreased to 20% in Hela cells when induced with 
cAMP, while transcription of VP8.1 in Jurka t ce lls was reduced to 61% upon cAMP 
induction (fig. 10). cAMP induction has little effect on pControl plasmid which carries 
the SV 40 promoter and enhancer. These results suggest that the Vp8.1 gene was down-
regulated through cAMP. However the down-regula tion was more pronounced in Hela 
cells than in Jurkat T cells. 
DISCUSSION 
The htP gene was first isolated with the belief that it was a T cell specific 
transcription factor. Expression analysis of the htf3 gene in cell lines from different 
lineages makes this unlikely (Chapter I). In addition to binding to the human TCR Vf3 
8.1 promoter , htf3 also binds to another T cell regulatory sequence, the mouse T cell 
receptor a. gene silencer (fig. 2). The comparison of the binding sites in both Vf38.l and 
the T CR a. silencer I reveals that the consensus sequence for htf3 binding is nine 
nucleotides. This consensus sequence is centered with a reverse oriented CACCC box, 
which was first characterized as an important promoter element for globin gene 
expression (3). Oligonucleotides containing five repeats of the CACCC box can 
specifically form a DNA-protein complex with bacterially-expressed htP protein in a 
gel-shift assay. Gel-shift assay analysis with the same C ACCC containing probe and 
nuclear extracts from different ce ll lines reveal a number of bands. Four common bands 
a re observed in nuclear extracts from Hela, U - 937 monocyte cell line, Ramos B cell line 
and the Jurka t T cell line , which may partially expla in the multiple mRNA species seen 
in Northern blot analysis of these four cell lines with the htl3 probe (Chapter I). No 
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specific band is observed in nuclear extracts from T cells. Interestingly, an extra fast-
moving band is detected in nuclear extracts from Hela cells, and not from the three 
hematopoietic cells. Whether this CACCC binding protein can regulate epithelial-
specific gene expression is not known. Since the ht13 gene is single copy (Chapter l ), 
different htj3 protein forms may result from alternative RNA splicing. The question of 
possible different forms of htj3 that can regulate gene expression is unanswered at this 
time. Also, gel-shift assay comparison of the CACCC containing probe with either in 
vitro translated protein from full length htj3 eDNA or cell nuclear extracts may tell us 
which band in the gel-shift assay with nuclear extracts corresponds to htj3 protein 
encoded by the gene that we have cloned. 
To find out how many genes are possibly regulated by the htj3 protein, both 
GGGTG and CACCC boxes were searched among different genes. Examination of 
sequence information from 14 mouse VJ3 and 5 human VJ3 gene promoters (21, 22) 
reveals that most of the Vj38 family members of both human and mouse have the 
GGGTG box. Only the mouse Vj38.l gene and the human Vj38.4 pseudogene have 
modified GGGTG boxes (fig. ll ). Among the other VJ3 members examined, only mouse 
Vf37 has a GGGTG box. In addition to VJ3 genes, other TCR regulatory sequences also 
· have GGGTG or CACCC boxes, including TCR a. and f3 enhancers of both human and 
mouse (23-26), and mouse TCR gene a. silencer I and II. TCR silencer I has four 
continuous repeats of the GGGTG box and one CACCC box (fig. 12). Functional 
analysis will be necessary to determine whether these GGGTG or CACCC boxes bind to 
transcription factors and activate gene expression. The CACCC box is not found in the 
TCR y enhancer (27). Although there is a CACCC box in the TCR o enhancer, DNase I 
footprinting assay shows no binding activity to that site (28). We believe that htj3 
protein may act as a major activator for TCR gene expression by binding to the 
GGGTG boxes in the TCR a. silencer to reverse the silencer activity in a.f3 T cells. 
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Comparison of htf3 gene expression in a.f3 versus y8 T cells may provide important 
information about regulation of TCR genes during ontogeny. 
In addition to T cell receptor genes. the CACCC box was first described in the 
globin gene promoter, and later was found in regulatory sequences of many genes (fig. 
13). Most of these CCCAC boxes are functional for the transcriptional activation of 
these genes. The general impression from fig. 11-fig. 13 is that the GGGTG box is 
more frequently used in TCR genes, and globin and other genes often have the reverse 
orientation of GGGTG (CACCC) for their transcriptional activation. The orientation of 
the CACCC box may not have much influence on transcription. In the rat tryptophan 
oxygenase gene promoter. it has been shown that both the orientation and number of the 
CACCC box do not affect the gene transcription significantly (29). Deletion of the htf3 
binding site which has a CACCC box in it dramatically reduces transcription activity. 
while addition of five repeats of CACCC box to the deleted Vf38. l promoter resulted in 
major increase of the transcriptional activity. The results clearly show that the CACCC 
box is very important for efficient transcription of the Vf38. l promoter. Although there 
is a CACCC box in the SV40 enhancer, it is not important for transcription in this 
system. p.:1. Vf38.l CAT plasmid which has deleted the CACCC box in the Vf38.1 promoter 
but carries the CACCC box in the SV40 enhancer only expresses basal transcriptional 
activity (fig. 7). One study has shown the upstream CACCC box in the human f3-globin 
gene promoter is unable to bind CACCC factor. in contrast to the strong effect of the 
proximal CACCC box on globin transcription. In spite of the existence of the upstream 
CACCC box. mutation at the proximal CACCC box greatly decreased globin gene 
transcription (30). DNase I footprinting assay analysis (fig. 2) indicates htf3 binds to the 
four continuous GGGTG boxes in the mouse a. silencer I very well. but significant 
binding is. not observed in the CACCC box located 101 nucleotides away. The sequences 
flanking the CACCC box may have a significant effect on the ability of its binding to 
transcription factors . 
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The importance of the CACCC box in gene transcription was first shown m the 
study of the 13-globin promoter. The C--*T transition at the first position of the hACCC 
box in the 13-globin promoter strongly decreased transcription (3 ). A CACCC box 
mutation in the slow /cardiac troponin C gene enhancer also resulted in approximately 
90% reduction of transcription relative to that observed with the wild-type enhancer (5). 
Similar results were obtained from the mouse porphobilinogen deaminase gene (31 ), the 
human 7S K RNA gene (31) and GATA-1 gene promoters (4). The function of the 
CACCC box in other T cell receptor genes has yet to be determined. 
The CAT assay of cotransfection with an expression plasmid that expresses the ht 
J3 protein and a reporter plasmid that has a human VJ38.l promoter containing CACCC 
box indicates that htf3 protein can activate Vf38.1 promoter transcription. Endogenous 
htf3 protein results in transcriptional activity in the absence of additional .htf3 protein. 
The observed 2-fold increase in activity was reproducible. Htf3 protein can reproducibly 
counteract the silencing activity of mouse TCR a silencer I (fig. 9). Cotransfection of 
the htf3 expression plasmid with pControl plasmid which has both the SV40 promoter and 
enhancer did not increase transcription. The antagonizing activity of htJ3 protein on the 
TCR gene a silencer may have interesting implications for TCR gene expression in aJ3 
and yo T cells. We speculate that perhaps in yo T cells, either htJ) protein is not 
expressed, or the htJ) protein is functionally different from that in aJ) T cells possibly 
due to post-translational modification, or the CACCC boxes in the TCR a silencer are 
not accessible to htJ) protein since a.J) and yo T cells may have different chromatin 
structure at the a/'6 locus. Any one of the above reasons may result in the silencing of 
the a locus in yo T cells. On the contrary, in a.J) T cells the actively expressed htf3 
protein may bind to the CACCC boxes in both silencer I and II, resulting in the relief of 
silencer activity, leading to the expression of the TCR a gene. The details of how htf3 
protein is involved in TCR a. gene activity of a.J) and yo T cells may help to explain the 
differentiation process of these two populations of T cells. 
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The interaction between the CACCC box binding protein and other transcription 
factors has been reported. CACCC binding protein is synergistic with NF-FI erythroid 
specific transcription factor (33), glucocorticoid receptor (29,34), and IL-4 (8) for 
particular gene expression. Since a cAMP response element (CRE) is just downstream of 
the CACCC box in the human Vl38. I promoter (fig. 1), induction by cAMP could 
decrease greatly the transcriptional activity of the Vl38. l promoter in Hela cells. This 
suggests cAMP may negatively regulate transcription from the cAMP response element 
in Vl38.I. CREB-2 protein has been shown to cause the repression of CRE-dependent 
transcription (35) . ..It is not clear whe ther CREB-2 is responsible for the normally 
observed repression of Vl38.l transcription in Hela cells. Jurkat T cells which actively 
express the Vl38. I gene were not significantly subject to negative regulation as Hela cells 
by cAMP. An intriguing possibility is that protein-protein interactions between htl3 and 
the CRE binding protein result in regulation of T cell receptor genes. 
Another interesting aspect about the CACCC box is that mutation at this binding 
site can cause disease. Mutation at position -87 (C--..T or C--..G) in the CACCC box of 
the globin promoter greatly decreases transcriptional activity of the 13-globin gene, and 
the natural mutation at that position has been shown to cause thalasemia (36-37). Our 
study also shows that the CACCC box is very important for T cell receptor gene 
transcription. Mutation at the CACCC box of TCR promotesr may cause inefficient 
expression of certain Vl3 genes, therefore influencing the immune response carried out 
by a population of T cells which normally use that Vl3 gene product together with a 
particular Va. gene product to recognize the MHC molecule and foreign peptide. 
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-90 -49 
AAAj3AAGTTG GGGGTGGT$ CCCATTCAGT GATGTCACTG 
-so - 11 
ACAGATGCAT TCTCTGGGGA TAAAATGTCA CAAAATTCAT 
- 10 +1 +30 
TTCTTTGCTC ATGCTCACAG AGGGCCTGGT CTAGAATATT 
83 
Figure 1 Nucleotide sequence of the 5' flanking region of the human Vf38.1 gene 
between -90 and +30. +I indicates the putative start site for mRNA synthesis. The htf3 
binding site is boxed. The putative cAMP response element (CRE) is double-underlined. 
Also, the TAT A box is underlined. 
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Figure 2 DNase I footprinting assay of mouse TCR a. gene silencer I, 1-309 bp 
fragment. Lane G, Maxam and Gilbert sequencing ladder. Lane 0, no protein extracts. 
Lane I and 2 contained I and 2 ~g of protein extracts from bacteria containing the 
pET3a-htJ3 expression plasmids. Lane C had 2 ~g of the control protein extracts from 
bacteria containing vector pET3a. The binding site is bracketed {163-193 ). Also, the 
CACCC box (62-66) that does not have significant binding activity is bracketed with a 
broken line. 
Human TCR vp8.1 promoter 
Mouse TCR u silencer I 
86 
htP binding site 
( - 87) GAAG 
(163) CTACGG 
G (-72) 
GTGGGGTGGGGGGC (19 3) 
87 
Figure 3 Comparison of the htP binding site in human TCR Vl38.l promoter ( -87 to -
72) and mouse TCR a. gene silencer I (163 to 193). The binding site in the Vl38.1 
promoter was defined in Chapter I, and the binding site in silencer I was determined in 
Figure 2. The homologous regions in both binding sites are boxed. 
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Figure 4 Gel-shift assay of synthetic oligonucleotides containing five repeats of the 
CACCC box with protein extracts from bacteria containing pET3a-htf3 plasmids. From 
left to right lanes, 0, 0.25, 0.5, I and 2 ~g of protein extracts from bacteria containing 








1 2 3 4 5 
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Figure 5 Gel-shift assay of synthetic oligonucleotides containing five copies of the 
CACCC box with nuclear extracts from various cell lines. Lane 1, no protein extracts. 
Lane 2, 3, 4 and 5 contained 10 J.l.g of nuclear extracts from Hela, Ramos B cell, U-937 
monocyte and Jurkat T cell lines respectively. The bands, Bl-B5 observed in the gel-
shift assay are indicated on the left side. 
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Figure 6 Identification of nuclear proteins which bind to the CACCC box. 32p labeled 
oligonucleotides containing five repeats of the CACCC box were incubated with 10 J.lg 
of nuclear extracts prepared from Hela cells or Jurkat cells. Binding reactions included 
20 or 50 ng of the indicated unlabeled competitor oligonucleotides. CACCC, unlabeled 
oligonucleotides containing five repeats of the CACCC box. GAL-4, unlabeled 



















































































































































Figure 7 Transcriptional activity of the human V()8.1 promoter. The constructs of pVJ3 
8.1CAT, p6VJ38.1CAT and p06Vf38.1CAT have been described in Materials and 
Methods. The transcription start site of the SV40 promoter is indicated by an arrow. 
(a). Hela cells were transfected with 2 J..lg of various VP8. 1 promoter constructs and 0.5 J..l 
g of CMV -lac Z using the liposome method. (b). Jurkat cells were transfected with 5 J..lg 
of various VJ38.l promoter constructs and 1 J..lg of CMV -lac Z using the DEAE-dextran 
method. In both cases, the amount of cell extracts used in the CAT assay were 
optimized according to the J3-galactosidase activities. 
Reporter plasmid (2~--tg) 
Expression plasmid (2uQ) 
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Figure 8 Activity of htl3 protein on the human Vj38. 1 promoter. 2 J..l8 of pVj38.lCAT 
reporter plasmids were cotransfected with 2 J..l8 of expression plasm ids pSG5 (Lane I) or 
pSG5-htj3 (lane 2) into Hela cells using the liposome method (15). Internal control of 

















































Figure 9 Activity of htl3 protein on the mouse TCR a. gene silencer. (a). Schematic 
organization of reporter and expression plasmids. The mouse TCR a. gene silencer I was 
inserted upstream of the SV40 promoter or downstream of the SV40 enhancer. The full 
length htl3 eDNA was inserted at the EcoRI site of the pSG5 vector, which has a SV40 
early promoter. The transcription start site of the SV 40 promoter is indicated by an 
arrow. (b). Effect of htl3 protein on TCR a. silencer I. Hela cells were cotransfected 
with a reporter plasmid (2 flg) and an activator plasmid pSG5-htl3 (2 flg) or the parental 
vector pSG5, together with 0.5 jlg of the internal control plasmid CMV -lacZ. The CAT 
activity of pControl. transfection is considered 100%, and the relative CAT activities for 





























































































Figure 10 Transcriptional activity of human VJ38.l promoter upon cAMP induction. 
The constructs of p VJ38.1 CAT and pControl have been described in Materials and 
Methods. (a). Hela cells were transfected with 2 J.tg of pVJ}8.1CAT or pControl and 0.5 
J.tg of CMV -lac Z using the liposome method with or without cAMP induction. (b). 
Jurkat cells were transfected with 5 J.tg of pVJ38.ICAT and l J.tg of CMV-lac Z using the 
DEAE-dextran method with or without cAMP induction. In both cases, the amount of 
cell extracts used in the CAT assay were optimized according to p-galactosidase 
activities. 
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vpa gene family member GGGTG box in promoter sequence 
Human vpa .1 T G G G G G T G G 
Human Vj38.2 T G G G G G T G G 
Human Vj38.3 T c T G G G T G A 
Human Vj38.4 T G G A G G T G G 
Human Vj38.5 T G G G G G T G G 
Mous e Vj38.1 A A G T G G T G G 
Mouse Vj38.2 G A A G G G T G T 
Mouse Vj38 . 3 AAG G G G T G T 
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Figure I I GGGTG boxes found in both human and mouse TCR Vf38 gene promoters. 
The GGGTG sequences are boxed, and the flanking sequences also are shown. Sequence 
are presented in the 5'---+3' transcriptional orientation of the gene. 
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GGGTG or CACCC box in TCR gene regulatory sequences 
Mouse TCR gene a silencer I G G G T G ( 4) 
c A c c c 
Mouse TCR gene a silencer II c A c c c 
Human TCR 13 e nhancer G G G T G 
Mouse TCR 13 enhancer G G G T G (3) 
Human TCR a enhancer c A c c c 
Mouse TCR a enhancer c A c c c 
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Figure I 2 List of GGGTG or CACCC boxes found in TCR gene regulatory sequences. 
Sequences are presented in the 5'--+3' transcriptional orientation of the gene. If more 
than one copy was found, the copy number is indicated in the bracket. 
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GGGTG or CACCC box in non-TCR gene regulatory sequences 
Various globin gene promoters c A c c c 
GATA- 1 promoter c A c c c 
Troponin C gene enhancer G G G T G 
H+/K+-ATPase 13 gene promoter c A c c c 
Porpholignogen Deaminase promoter c A c c c 
Glucocorticoid receptor promoter c A c c c 
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Fig ure 13 GGGTG or CACCC box found in gene regulatory sequences other than TCR 
genes. Sequences are presented in the 5'---+3' transcriptional orientation of the gene. 
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Chapter 3 
Isolation of a Mouse eDNA That is Homologous to the Human T cell Receptor Promoter 
Binding Protein HtJ3 at Zinc Finger Region 
109 
ABSTRACT 
A mouse zinc finger protein (M-zif) has been isolated and characterized. It has four 
fingers in the zinc finger domain, the putative DNA binding domain. A glutamine-rich 
region also was found, which may be involved in transcriptional activation. A 
previously reported eDNA molecule was shown to contain the coding regions of both IL-
2Rcx receptor and M-zif genes. The results presented here indicate that the eDNA is a 
chimeric molecule resulting from cloning artifact. The zinc finger domain of M-zif is 
highly homologous to that of htP, a human T cell receptor VP8.l gene promoter binding 
protein. They may have similar DNA binding sites. However, M-zif is not the mouse 
equivalent of htp. 
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INTRODUCTION 
The zinc finger domain is a sequence-specific DNA binding motif that was 
originally identified in the Xenopus /aevis transcription factor TFIIIA (1). Since then, 
many transcription factors with the zinc finger motif have been found in different 
systems, notably, the yeast ADRI (2), the Drosophila segmentation genes Kruppe/ and 
Hunchback (3-4), and the mammalian Spi factor (5-6). DNA sequence analysis of these 
cloned genes indicates they contain regions that strongly resemble the zinc finger motif 
of TFIIIA. The typical zinc finger motif consists of approximately 30 amino acids with 
two cysteine and two histidine residues that form the domain structure by coordinating a 
zn2+ ion (7). The region of 12 amino acid residues between the Cys-His pair usually 
are basic and hydrophobic, and may be responsible for DNA sequence-specific binding 
(8). Another remarkable feature about the zinc finger motif is that there is a region of 
sequence between the last histidine of one finger and the first cysteine of the next, 
which is very conservative among the zinc f inger-containing proteins of all species (7). 
Zinc finger proteins have a variety of functions . Yeast ADRI is a transcription factor 
required for the transcriptional activation of the alcohol dehydrogenase gene (2), while 
Spl is a general transcription factor that controls many cellular and viral genes (8). The 
Drosophila segmentation genes Kruppel and Hunchback are involved in control of 
development in Drosophila (3-4), the human zinc finger protein ZFY, located on the Y 
chromosome, is the major sex-determining gene (9), GLI (IO) and Wilm's tumor genes 
(II) are proto-oncogenes. Other zinc finger protein, for example, EGRI and EGR2 are 
induced by differentiation signals ( 12- I 5). 
The basic structure of a zinc finger protein consists of an antiparellel 13- sheet 
followed by a helix with a zn2+ ion coordinated to the two cysteines in the loop and to 
the two histidines (I 6- I 8). Zinc finger proteins are able to bind ON A sequence 
specifically. Both the zinc-finger region and zinc are necessary for binding. In Chapter 
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1, a human T cell receptor (TCR) VP8.1 gene promoter binding protein htP has been 
isolated and characterized. Further study (Chapter 2) identified htP as a CACCC 
binding protein, which is essential for human TCR VP8. 1 gene expression. The results 
from a GenBank search with the htP gene as a query sequence indicated that htP is 
homologous to the noncoding strand of one of the mouse interleukin-2 receptor a. chain 
(IL-2Ra.) cDNAs, IL-2R cDNA-J ( 19). The noncoding strand of the 5' untranslated 
region of the mouse IL-2Ra. has the potential of encoding a mouse zinc finger protein 
(M-zif). IL-2Ra. and M-zif mRNA are transcribed from different DNA strands and 
transcription proceeds at opposite directions (fig. I). The M-zif gene has been cloned 
and analyzed in terms of its interesting relationship with IL-2R a. gene. The sequence 
analysis of M-zif, its comparison with htP and its functional implication also are 
reported here. 
MATERIAL AND METHODS 
Oligonucleotides 
The oligonucletides used for polymerase chain reaction (PCR) of the M-zif gene 





5 1 TGAGACAACACAGCCAGGTTACCC 3' 
5 1 CCCACCACCACCATCACCACCACC 3 1 
5 1 TGCCCGACAACTGGGTACTAT 3 1 
5' CCCAACATCAGCAAGCGTGGC 3 1 
The location of all the primers are shown (fig. I) 
RT-PCR (reverse transcription of RNA followed by the polymerase chain reaction) 
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Poly (A)+ RNAs were prepared as described in Chapter 1. Mouse T cell line 
EL-4 poly (A)+ RNA (0.5 J.Lg) was used for reverse transcription using eDNA 
SYNTHESIS SYSTEM PLUS (Amersham). Primer 1 (0.25 J.LM) was used for priming the 
first strand eDNA, then 5 J.Ll of first strand eDNA primed by primer 1 was used for 
PCR with either primer 1 and 2, or primer 1 and 3, or primer 1 and 4. The PCR 
conditio ns are as follows: 92°C, 45 sec; 60°C, 60 sec; 72°, 90 sec, for 30 cycles. Finally 
the PCR products were resolved on an 1 o/o aga rose gel. The DNA fragments were 
isolated and subcloned into the pUC19 vector for sequence analysis (20). 
Genomic DNA PCR 
Mouse BALB/c liver genomic DNA (Clontech) (0.1 J.Lg) was used for PCR with 
either primer I and 3, or primer I and 4. The PCR was performed at: 92°C, 45 sec; 55 
°C, 90 sec; 72°C, 180 sec, for 30 cycles. The PCR products were resolved on an I% 
agarose gel for Southern blot analysis. 
Library construction and screening 
Mouse T cell line EL-4 poly (A)+ RNA (2.5 J.Lg) was used for eDNA synthesis by 
following the procedure of eDNA SYNTHESIS SYSTEM PLUS (Amersham). Oligo-dT 
was used for priming the first strand eDNA. The eDNA was then ligated to the A.gtll 
vector (Stratagene), and packaged using the In Vitro Packaging System for Lambda DNA 
(Amersham). The EL-4 eDNA library (A.gtll) was screened using a 0.75 kb DNA 
fragment as a probe, which is amplified from EL-4 poly (A)+ RNA with Primer I and 2 
by the PCR method. The screening was performed according to the manufacturer's 
protocol. The EcoRI inserts from positive plaques were subcloned into pUC19 for 
sequence analysis using the dideoxy chain termination method for both strands. 
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Southern and Northern analysis 
Mouse BALB/c liver genomic DNA (5 )lg) was used for Southern blot analysis. 
Preparation of poly {A)+, Southern and Northern blot analyses were done as described in 
Chapter 1. Both Jurkat human T cells and EL-4 mouse T cells were cultured at 37°C, 
and the poly (A)+RNAs from both cell lines were isolated. 
RESULTS 
Isolation of the M-zif gene 
To analyze the relationship between IL-2Ra. and M-zif genes, and whether the 
M-zif gene is actively transcribed, the RT -PCR cloning method was used for isolating 
the M-zif gene. Primer 1 that complements the M-zif gene coding strand was used for 
priming first strand eDNA synthesis, and PCR amplification of the first strand eDNA 
with Primer I and 2 was performed. A 0.75 kb DNA fragment was isolated from 
Primer 1 and 2 amplified PCR products. Sequence analysis of this 0.75 kb fragment 
verified that it is part of the M-zif gene. A EL-4 eDNA library (A.gtll) was 
constructed, and 106 plaques were screened with the M-zif 0.75 kb fragment as a probe. 
Two positive plaques were found. The two M-zif cDNAs are 0.65 kb (M-zif 2) and 1.3 
kb (M-zif 7) in length. M-zif 2 and M-zif 7 overlap by approximately 0.65 kb in the 5' 
region (fig. 2). 
DNA sequence of M-zi[ 
The DNA sequence of M- zif was determined (fig. 3). Sequence analysis of the 
M-zif gene reveals a long open reading frame of 732 nucleotides which is terminated 
with two in-frame stop codons. Since the open reading frame continues to the 5' end of 
the eDNA for both M-zif 2 and M -zif 7, very likely the full length eDNA has not been 
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isolated yet. The partial M-zif eDNA encodes a protein of 244 amino acids. Analysis 
of the M-zif amino acid sequence translated from the cDNAs reveals a few interesting 
features. Firstly, there is a zinc finger domain at the 3' end of the open reading frame. 
The first two fingers have the typical finger motif of Cys-X2-Cys-X3-Phe-Xs-Leu-
X2-His -X3-His. The third and fourth fingers have the modified forms of Cys-X2-
Cys- X3-Phe-X8-His-X3-His and Cys-XrCys-X3-Phe-Xs-Leu-X2-His-X3-Cys 
respectively. The results from a GenBank search indicate that the M-zif gene encodes a 
novel zinc finger protein. Secondly, there is a glutamine-rich region (residue 17 -25) in 
the 5' region of the. M-zif gene. Finally, a segment rich in basic amino acids is found 
upstream of the zinc finger domain( residues 53-70) 
Southern blot and Northern blot analysis 
To determine whether the M-zif gene has one copy or multiple copies, BALB/c 
mouse liver DNA was digested with four restriction enzymes for Southern blot analysis 
(fig. 4). A single band was seen with each restriction enzyme digest. M-zif gene 
expression was studied in the EL-4 murine T cell line and Jurkat human T cell line with 
a 32r-Iabeled M-zif 2 fragment. A 5 kb band was detected in both RNA samples (fig. 
5). 
Genomic DNA PCR and RT-PCR analysis of M-zif gene 
Attempts were made to amplify the mouse genomic DNA fragment that includes 
the protein coding regions of both M-zif and the mouse IL-2 receptor a. gene using the 
PCR method. Primer l and 3, or Primer 1 and 4 were used for PCR amplification of 
mouse genomic DNA (see figure I). RT-PCR also was performed. The first strand 
eDNA was synthesized by using Primer 1, then the eDNA was subject to PCR 
amplification with Primer I and 2, or Primer 1 and 3, or Primer l and 4. The PCR 
products from both genomic DNA and RT -PCR were used for Southern blot analysis 
with M-zif 2 eDNA as a probe. There was a 0.75 kb band detected with RT -PCR 
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products synthesized with Primer I and 2, which was described earlier, but no bands can 
be detected from either genomic DNA PCR or RT -PCR products amplified with either 
Primer I and 3 or Primer I and 4. (fig. 6). 
DISCUSSION 
In Chapter l and 2, a novel zinc finger protein htP, which binds to the human T 
cell receptor VP8.1 .gene promoter, has been isolated and functionally characterized. 
GenBank search with htP as a query sequence identified that it is homologous to the 
noncoding strand of one of the mouse IL-2 receptor gene a. (IL-2Ra.) cDNAs, IL-2R 
cDNA-J (19). The 5' untranslated region of the IL-2R a. gene encodes a mouse zinc 
finger protein (M-zif), but the IL- 2R a. gene and M-zif genes are transcribed in 
opposite orientation (fig. 1). To determine if the M-zif gene is located next to the IL-
2R a. gene on the chromosome and whether it is the mouse counterpart of htp, molecular 
cloning of the M-zif gene was necessary. M-zif was cloned by using the polymerase 
chain reaction method. Two M-zif eDNA clones were isolated by screening a eDNA 
library made from mouse EL-4 cell derived mRNA probed with a M-zif gene PCR 
fragment. The sequence analysis of the M-zif gene indicated it has a zinc finger domain 
with four fingers in it. The first two finger motifs have the general form, while the 
third and fourth fingers have been modified. Especially the fourth one, instead of 
having Cys- Cys and His-His pairs, it has Cys-Cys and His-Cys pairs. The C2-H-C type 
of finger has been found in the human IFN-P gene promoter binding protein PRDII-
BFl (21) and the sterol regulatory element binding protein (22). The C2- H2 type of 
finger, which was found in the first three fingers of M-zif, was shown to be sufficient 
for specific DNA binding of the transcription factor TFIIIA (I) and Spl(8). The C2-H-
C finger, which is the fourth finger of M-zif, is required for binding to single -stranded 
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DNA or genomic RNA of retroviruses (23-24). In the case of PRDII-BFI (21), the c2-
H-C finger is not required for human IFN-13 gene promoter binding. The function of 
the C2-H-C finger in the M- zif gene is yet to be identified. The comparison of finger 
regions between htl3 and M-zif indicate they are 75% homologous (fig. 7). Surprisingly 
the two finger domains are almost identical at those amino acid residues which 
presumably interact with DNA (boxed amino acids in fig. 7) according to the crystal 
structure analysis of a mouse immediate early protein Zif268 (25). Therefore, possibly 
M-zif recognizes the same or very similar DNA sequence as htl3. Besides the zinc finger 
region, M-zif has a .. short glutamine-rich region that may be involved in transcriptional 
activation. The glutamine-rich region has been characterized as a transcriptional 
activation domain in the human Sp I transcription factor (8). A highly positively-
charged region also is found, which may be the putative region responsible for nuclear 
localization of M-zif (26). Once the full length eDNA of M-zif has been isolated, 
further sequence analysis can be pursued. 
The possibility that the IL-2R a. and M - zif genes are located at the same location 
on the chromosome is intriguing because the coding region of M-zif overlaps with the 5' 
untranslated region of IL-2Ra.. The expression of one gene may have a direct effect on 
the expression of the other gene because of structural changes of that region of 
chromatin. Southern blot analysis of mouse DNA with a M-zif probe revealed a single 
band in mouse DNA digests with either EcoRI (5 kb) or Hindlll (7.4 kb) or BamHI (1.35 
kb) or Xbal (6.8 kb). The Southern blot results with an IL- 2Ra. probe revealed multiple 
bands for each of five restriction enzyme d igestions (27). A band approxima tely 5 kb 
can be seen on both blots with EcoRI digestion. From Southern blot results, the 
question of whether M - zif and IL- 2Ra. are loca ted adjacent but in opposite orientation 
to each other cannot be resolved. Northern blot analysis of the murine EL-4 cell !ine 
with a M-zif probe reveals a single band, approximately 5 kb. However, the Northern 
blot results of the same cell line with an IL-2Ra. probe that is located in the coding 
I 17 
region of IL-2Ra. indicated a 4. I kb band only. At least two bands on the Northern blot 
detected with a M-zif probe were expected, representing the two transcripts from the 
IL-2Ra. promoter and the M-zif promoter. At least one band was expected to be 
observed on Northern blot analysis with IL-2Ra. probe, which represents the transcript 
from IL-2Ra. promote r. In short, a common band that represents the transcript from the 
IL-2Ra. promoter is supposed to be detected on Northern blot analysis with the M-zif 
probe and the IL-2Ra. probe if the IL-2R cDNA-J is not a chimeric molecule. 
Northern blot analysis of the EL- 4 cell line with both M- zif and IL-2Ro: probes 
revealed no commo.n band, suggesting the IL-2R cDNA-J is probably a chimeric 
molecule that combined the M-zif and IL-2Ro: eDNA molecules. In addition, when two 
sets of primer pairs, which complement the protein coding regions of either the IL-2R o: 
gene or the M-zif gene, were used for mouse genomic DNA PCR and RT -PCR 
amplification, there were no bandi seen ·on a Southern blot detected with the M-zif 2 
probe. An expected band was observed on the control lane in which the PCR product 
amplified with two primers located in the M-zif coding region was loaded. On the basis 
of these data, very likely the IL-2R cDNA-J described by Froussard et al. (19) was a 
cloning artifact (20). The chimeric DNA molecule has one eDNA from the M-zif gene 
and another from the IL-2R o: gene. As a matter of fact, the authors also raise the 
possibility that the IL-2R cDNA- J represents a cloning artifact. The comparison of the 
IL-2R cDNA-J sequence with the murine p55 IL-2R eDNA (28) and the human IL-2R 
gene (29- 30) show they diverge extensively in the 5' untranslated region. Although the 
IL-2R cDNA- J is very likely a chimeric eDNA molecule, some genes may truly overlap 
with each other because of their related functions. The transcription of one gene may 
change the chromatin structure and make the other gene accessible to the transcription 
machinery, causing the activation or repression of that gene. 
Since M-zif and htf3 sequences have almost no homology except for the finger 
domain, very likely M-zif is not the htf3 equivalent in mouse. Northern blot analysis of 
118 
both the murine EL-4 and the human Jurkat cell lines with a M-zif probe indicates a 
single band of approximately 5 kb. Northern blot analysis of the Jurkat cell line with a 
htl3 probe reveals three bands, approximately 4.2. 7.6 and 8.6 kb (Chapter I). Both 
sequence and Northern blot results clearly demonstrate that M-zif is not the htl3 
counterpart in mouse. Although htP and M-zif are different genes and may carry out 
different gene regulating functions. they possibly recognize very similar or identical 
DNA sequences because of their highly homologous zinc finger domains. This may 
represent a mechanism of how zinc finger proteins regulate gene expression positively or 
negatively. This speculation is based on the fact that htl3 and M-zif have almost 
identical amino acid residues that are currently known to be important for sequence-
specific binding. The possibility that other amino acid residues in the finger or out of 
the finger region also contribute to sequence-specific recognition by both htj3 and M-zif 
cannot be ruled out. Comparing the binding of htj3 and M-zif proteins with their 
putative DNA binding sites will be useful for solving the problem. 
Finally, many zinc finger proteins have been characterized since the zinc finger 
motif first was described in TFIIIA. These proteins have been shown to have both 
sequence-specific binding and gene regulation functions. How the amino acids in the 
finger interact with nucleotides in the DNA sequence is still not very clear. There is 
speculation that a code system may dictate the interaction between amino acid residues 
and nucleotides (31). Such a system would predict which amino acid residue can interact 
with which nucleotide. Accumulation of additional data on zinc finger protein/DNA 
interaction will facilitate the derivation of rules for such a code. 
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Figure 1 The IL-2 receptor (IL-2R) a gene and the M-zif gene are contained in the 
same eDNA molecule , the IL-2R cDNA-J (20). In this diagram, the two genes are 
tra nscribed in opposite directions, indicated by the arrows. The locations of the arrows 
do not indicate the actual transcriptional start s ites since they are not known for both 
genes. The IL- 2Ra and M - zif coding regions are represented by black and blank boxes 
respectively, and the region with hatched lines indicates the zinc finger domain of M-zif 
gene. P 1, P2, P3 and P 4 are the primers used for polymerase chain reaction. The 
locations and directions of these primers are shown in the figure. The location of M-zif 
2 probe also is indi<;;ated. 
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Figure 2 cDNAs and predicted protein structure of M-zif. The overlapping cDNAs M-
zif 2 and M-zif 7 were isolated from an EL-4 T cell eDNA library. Restriction enzyme 
sites: P, Pst I; S, Sac I. A schematic diagram of the predicted the M - zif protein 
structure is shown, with 2 eDNA clones aligned to the protein structure. The interesting 




R f: G G S II G V I Q 0 L S L L II @ II A @ 20 
Gl CAGCAACCGGCCCAGCIICCACCGCGATGTATTACTGAGCAGCGGTAGCAGGACTGATGAG 120 
2l @ @ P A @ II II R D V L L S S G S R T D E 40 
l 2 l CACGGCI\ACCAGGAGCCAAAGCAGGACGCriiACGTCAAAAAGGCAAAGAGGCCAl\.1\GCCA 180 
4 l II G N Q E P K Q D A N V ~ ~ !':_ !S_ .!3_ £. !S_ £. GO 
101 GIIATCTCAGGGI\ATCI\AAGCCAAGAGGIIAGCCAAGTGCATCTTCCAAACCTTTGGTTGGA 240 
Gl E ~ Q G I ~ !':_ ~ R K P S II S S K P L V G 00 
241 GIIGGG/\GI\AGGTGCCGTCCTGTCCCCIIAGTCIIGIIAACCTCIITIITCTGTGIITCACTGTIIGT 300 
01 E G E G A V L S P S Q K P H I C 0 II C S 100 
3 01 GCTGCTTTCAGGAGCTCCTACCACCTGCGGIIGIICATGTCCTCATCCIICACGGGCGIIAAGG 360 
101 A A F R S S Y H L R R H V L I H T G E R 120 
361 CCTTTCCAGTGCAGCCAGTGTAGTATGGGTTTCGTCCAGAAATACCTACTGCAGAGACAC 420 
121 P F Q C S Q C S M G F V Q K Y L L Q R H 140 
421 GAGAAAATTCACAGCAGAGAGAAACCCTTTGGGTGCGATCAGTGCAGCATGAAGTTTATT 400 
141 E K I H S R E K P F G C 0 Q C S M K F I 160 
481 CAGAAGTACCATATGGAGAGACACAAGAGGACACATAGTGGAGAAAAGCCATACAAGTGT 540 
161 Q K Y H M E R H K R T H S G E K P Y K ~ 180 
541 GACACTTGCCAACAGTATTTTTCAAGGACTGACAGATTGTTGAAGCACAGGCGCACGTGT 600 
181 D T C Q Q Y F S R T D R L L K H R R T C 200 
601 GGTGAAGCCATAGCAAAAGGAGCCGCTAGTGCAGAACCTGGGTCATCAAACCATAACAGT 6 60 
201 G E A I A K G A A S A E P G S S N H N S 220 
661 ATGGGTAACCTGGCTGTGTTGTCTCAGGGAAATACAAGTTCCTCAAGGAGAAAGTCGAAT 720 
221 M G N L A V L S Q G N T S S S R R K S N 240 
7 21 CGAAAACATAGCTAGTGAAAATAAGGAACACAAGACTGGCAAAACAAATGAATCACAAAT 7 8 0 
241 R K H _ S * * 260 
7 81 GTCAAACAATATAAACATGCAGAGTTATTCAGTAGAAATGCCTACTGTGTCTACCAGTGG 8 4 0 
8 41 GAGCATAATTGGCACTGGAATAGATGAACTGCAGAAAAGGGTGCCAAAATTGATCTTTM 900 
901 GAAAGGAAGCAGAAAGMTGCAGATAAAAGCTACCTTAATTTTGTGTCACCGTTACCAGA 960 
9 61 CGTAGTTGGGCAGAAATCCTTGTCTGGTAAGCCAGGTGGCTCACTTGGCATCGTATCGAA 1020 
1021 TAATAGTGTGGAGACCATTAGTCTTCTCCAAAGTACAAGTGGCAAGCAAGGCCCGATAAG 10 80 
1081 TAGTAATTATGATGATGCCATGCAGTTTTCAAAGAAGAGAAGATACCTACCAACTGCCAG 1140 
1141 CAGCAACAGTGCCTTTTCTATCAATGTAGGACACATGGTCTCCCAGCAGTCAGTCATTCA 1200 
1201 GTCTGCAGGGGTCAGTGTTTTGGACAATGAGGCGCCATTGTCACTTATTGACTCCTCAGC 12 60 
12 61 TCTAAATGCTGAAATT AAGTCTTGTCACGACAAGTCTGGAATTC 130 4 
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Figure 3 DNA sequence and predicted amino acid sequence of M-zif. The amino acid 
sequences predicated from the longest open reading frame of M-zif are shown. The zinc 
finger motifs are shown with an underline; the glutamine-rich region is indicated b y a 
double line and glutamines are circled. The basic segment which is located before the 
zinc finger is shown with broken lines. The two stop codons in the longest open reading 
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Figure 4 Southern blot analysis of mouse liver genomic DNA probed with the M-zif 2 













Figure 5 Northern blot analysis of poly (A)+ RNA from EL-4 and Jurkat cell lines. 
Poly (A)+ RNA (10 J.l&) was loaded on each lane. The blot was hybridized with the 0.65 























I I I I 
1 2 3 4 5 
132 
Figure 6 Southern blot analysis of genomic DNA PCR and RT -PCR products with M-
zif 2 probe. Lane I and 2, genomic DNA PCR with Primer I and 3 and Primer I and 4 
respectively. Lane 3-5, RT -PCR with Primer I and 2, Primer I and 3 and Primer I and 
4 respectively. 
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Figure 7 Alignment of zinc finger domains between htP and M-zif. The top line shows 
the htP finger region (amino acid residues 173-278), and the bottom line indicates the 
M-zif finger domain (amino acid residues 96-200). The amino acid residues which are 




A gene encoding a human zinc finger protein, htf3, has been isolated and 
characterized. It has a zinc finger domain of Cys2-X 12-His2 class and an acidic 
domain. The zinc finger domain is one of the well-known DNA binding domains (1). 
The amino acid residues that are located between the second conservative cysteine and 
the first conservative histidine are possibly responsible for the DNA binding function 
(2). Usually positively charged amino acid residues are found in that region. Each htf3 
zinc finger has a few positive amino acids, which may interact with guanines of the 
CACCC box. The acidic region is a putative transcription activation domain. The acidic 
domain first was d~cribed in the yeast transcription factor GAL4 (3). Features of the 
acidic domain generalized from GAL4 factor are: negative charges and a.-helical 
structure. The acidic domain of htj3 has both of these features. Since htf3 has the two 
well-characterized domains for a transcription factor, we believe it is a novel 
transcription factor involved in gene regulation. 
In terms of its function, htf3 first was thought to be a T cell-specific 
transcription factor. However, further study indicated that it is a general transcription 
factor that bind to the well-known CACCC box. The CACCC box first was shown to 
be essential for globin gene transcription (4), and later found to be important for the 
expression of many other genes (5-9). The results in this thesis also indicate that the 
CACCC box is necessary for efficient transcription of human T cell receptor gene Vf3 
8. I . Htf3 can activate the transcription of the human TCR Vj38.1 gene. Since the htf3 
gene is expressed in Hela cell, B cell, macrophage and a.f3 T cell lines, very likely htf3 
functions as a general transcription factor by interacting with the CACCC box in various 
gene regulatory sequences. 
How the htf3 protein works as a general transcription factor in not clear. Since ht 
f3 has an acidic domain that is even more negatively charged than that of yeast 
transcription factor GAL4, it will be interesting to determine if htf3 interacts directly 
with the protein TFIID that is a TAT A box binding protein. TFIID has been proposed 
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as the target of the acidic activation region (3), and the interaction between herpes virus 
protein VP16 that bears an acidic activation region and TFIID has been reported {10). 
Investigations of the interaction between ht~ and TFIID (fig. l) will be very important 
to understand how ht~ works as a transcription activator. There is a cAMP response 
element (CRE) just adjacent to the CACCC box in the human V~8.1 promoter. Possibly 
there is a protein-protein interaction between CRE binding protein and ht~. The 
interaction between the CACCC binding protein and other transcription factors has been 
reported (9, 11-12). A speculation is that some transcription factors may bind to ht~ 
that bears an acidic .-activation domain that interacts with TFIID (fig. 2). This may 
explain how these transcription factors activate gene expression. 
Besides binding to the human TCR V~8.1 promoter, ht~ also binds to the mouse 
TCR a. silencer. The CACCC box has been observed in many TCR ~ gene promoters 
(13-14), TCR a. and ~enhancers (15-18), and the mouse TCR a. silencer (19). The 
CACCC box in the TCR 8 enhancer does not have binding activity (20), and there is no 
CACCC box in the TCR y enhancer (21). The regulatory function of ht~ that binds to 
the CACCC box in human TCR V~8.1 promoter and mouse TCR a. silencer has been 
studied. On the basis of the above facts, we propose that the CACCC box binding 
protein may act as a major regulator of TCR gene expression. In a.~ T cells, the 
CACCC factor interacts with the CACCC box in TCR a. and ~ enhancers to activate 
transcription. Also, the CACCC factor binds to the TCR a. silencer to relieve its 
silencing effect on the TCR a. enhancer. In y8 T cells, the CACCC factor is not 
expressed or not functional, resulting in the TCR a. silencer to be active, which 
decreases the enhancing effect of the TCR a. enhancer. Hence, the TCR a. gene 
expression is repressed in y8 T cells. Comparison of the ht~ gene expression in a.~ T 
cells versus y8 T cells and functional analysis of the CACCC boxes located in TCR a. and 
~ enhancers will be very important for revealing the regulatory functions of the CACCC 
factors on TCR gene expressions in both a.~ and y8 T cells. 
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In addition, a novel gene encoding a murine zinc finger protein (M-zif) has been 
cloned. M-zif is highly homologous to htfl at the zinc finger domains, although M-zif is 
not the htP counterpart in mouse. Since M-zif and htP have almost identical amino acid 
residues that are currently known to be important for sequence-specific binding {22), 
they may recognize very similar or identical DNA sequences. The next goal will be to 
test the binding of M-zif to the CACCC box. If M-zif can bind to the CACCC box, 
the regulatory functions carried out by htP and M-zif will become very interesting. The 
observation that two different transcription factors can bind to the same site may 
provide insight into. a new mechanism of how zinc finger proteins regulate gene 
expression. Finally, it also is important to clone the htl3 counterpart in mouse since htP 
has been shown to regulate the murine TCR o. gene silencer. Northern blot analysis of 
the human Jurkat cell line with a htl3 probe did not reveal any band. Using a htl3 probe 
to screen the mouse eDNA library at low stringent conditions may be an appropriate 
approach to isolate the murine equivalent of htl3. 
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Fig. 1 The model of gene activation by the htP protein. The htP protein has a zinc 
finger domain for DNA binding and an acidic activation region. The zinc finger 
domain binds to the CACCC box and the acidic domain contacts the TFliD that binds at 
the TAT A box. These interactions may loop the intervening DNA since the CACCC 




Fig. 2 The model of interaction between the htl3 protein and the other transcription 
factor. The htl3 protein binds to the CACCC box and interacts with the TFIID that 
binds to the TAT A box. Another transcription factor, termed protein X, binds to its 
cognate X site and interacts with htl3 protein, then increases or decreases the gene 
transcriptional activity. Again, these interactions may loop the intervening DNA. 
